FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Narod

Research Profile

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Concepts & Ideas

Procedures

Living Beings

Heterozygote

Phenomena

Founder Effect

Co-author Network

Publications

TOP 3
Pål Møller; Steven A Narod; Astrid T Stormorken; Ping Sun; Anita Vabø; Neal Clark; Anne Irene Hagen; Marit Muri Holmen; Christoffer Jonsrud; Lovise Maehle
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Indra Rani Gupta; Kevin C H Ha; Jacek Majewski; Steven A Narod; David S Rosenblatt; Mohammad Reza Akbari; David Auguste; Cindy Baldwin; Chantal Bernard; Martin Bitzan; Jasmine El Andalousi; Somayyeh Fahiminiya; Tomoko Takano
ARHGDIA: a novel gene implicated in nephrotic syndrome.
Kelly A Metcalfe; tulin cil; Andrea Eisen; May Lynn Quan; Ping Sun; Steven A Narod
The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Narod (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pål Møller; Steven A Narod; Astrid T Stormorken; Ping Sun; Anita Vabø; Neal Clark; Anne Irene Hagen; Marit Muri Holmen; Christoffer Jonsrud; Lovise Maehle
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Breast cancer research and treatment 2013;139(1):155-61.
2013: Indra Rani Gupta; Kevin C H Ha; Jacek Majewski; Steven A Narod; David S Rosenblatt; Mohammad Reza Akbari; David Auguste; Cindy Baldwin; Chantal Bernard; Martin Bitzan; Jasmine El Andalousi; Somayyeh Fahiminiya; Tomoko Takano
ARHGDIA: a novel gene implicated in nephrotic syndrome.
Journal of medical genetics 2013;50(5):330-8.
2013: Kelly A Metcalfe; tulin cil; Andrea Eisen; May Lynn Quan; Ping Sun; Steven A Narod
The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception.
Cancer 2013;119(9):1722-8.
2013: Eileen Rakovitch; Refik Saskin; Sandip Sengupta; Carole Taylor; Deva Thiruchelvam; Alan Tuck; Bruce Youngson; Susan J Done; Leela Elavathil; Wedad Hanna; Prashant A Jani; Iwa Kong; Naomi Miller; Steven A Narod; Sharon Nofech-Mozes; Lawrence Paszat
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Breast cancer research and treatment 2013;138(2):581-90.
2013: Tuya Pal; Robert Royer; Devon Bonner; Lisa Kessler; Jongphil Kim; Alvaro N A Monteiro; Steven A Narod; Susan T Vadaparampil
Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
The breast journal 2013;19(2):189-92.
2013: Steven A Narod; A Risch; Barry Rosen; Ping Sun; I Fan; J R K Moody; J R McLaughlin
Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations.
Clinical genetics 2013;83(3):232-7.
2013: Steven A Narod; Kenneth Offit; Olufunmilayo I Olopade; Andre Robidoux; Mark Robson; Ping Sun; Nadine Tung; Henry T Lynch; Kelly Metcalfe; Tomasz Byrski; William D Foulkes; Elizabeth Gaughan; Parviz Ghadirian; Tomasz Huzarski; Ania Jakubowska; Charmaine Kim-Sing; Jan Lubinski
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Breast cancer research and treatment 2013;138(1):273-9.
2013: John R McLaughlin; Joel Moody; Isabel Fan; Tuya Pal; Harvey A Risch; Barry Rosen; Thomas A Sellers; Patricia A Shaw; Ping Sun; Steven A Narod
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
Journal of the National Cancer Institute 2013;105(2):141-8.
2013: Katrzyna Jaworska; Karol Krzystolik; Marcin Lener; Jakub Lubiński; Jan Lubinski; Antoni W Morawski; Magdalena Muszyńska; Steven A Narod; Grzegorz Sukiennicki; Mieczysław Sulikowski; Ping Sun; Janusz Wójcik; Piotr Woloszczyk; Cezary Cybulski; Tadeusz Dębniak; Katarzyna Durda; Tomasz Grodzki; Satish Gupta; Ewa Jaworowska; Anna Jakubowska
A low selenium level is associated with lung and laryngeal cancers.
PloS one 2013;8(3):e59051.
2013: Robert K Nam; Laurence H Klotz; Calvin Law; Yuna Lee; Ying Liu; D Andrew Loblaw; Refik Saskin; Arun Seth; Andrew E Simor; Aleksandra Stanimirovic; John Trachtenberg; David R Urbach; Steven A Narod
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
The Journal of urology 2013;189(1 Suppl):S12-7; discussion S17-8.
2013: Amy Finch; John McLaughlin; Kelly A Metcalfe; Joan Murphy; Jaclyn Chiang; Rochelle Demsky; Lorraine Elit; Mary Jane Esplen; Barry Rosen; Caitlin Springate; Steven A Narod
The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
Psycho-oncology 2013;22(1):212-9.
2012: Laura García-Jiménez; Gustavo Gutiérrez-Espeleta; Steven A Narod
[Descriptive epidemiology and molecular genetics of hereditary breast cancer in Costa Rica].
Revista de biología tropical 2012;60(4):1663-8.
2012: Mohammad R Akbari; Aniruddh Kashyap; Wojciech Kluźniak; Song Li; Jan Lubinski; Janusz Menkiszak; Steven A Narod; Rachelle Rodin; Robert Royer; Dominika Wokolorczyk; Cezary Cybulski
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
Breast cancer research and treatment 2012;136(3):907-9.
2012: Jeanna M McCuaig; Steven A Narod; Ana Novokmet; Susan R Armel; Rochelle Demsky; Ophira M Ginsburg; David Malkin
Routine TP53 testing for breast cancer under age 30: ready for prime time?
Familial cancer 2012;11(4):607-13.
2012: Domenico Coppola; Andrea Doty; Jimmy Fulp; Sanja Galeb; Ji-Hyun Lee; John McLaughlin; Steven A Narod; Santo V Nicosia; Joellen Schildkraut; Thomas A Sellers; Zachary Thompson; Tuya Pal
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.
Anticancer research 2012;32(11):4963-9.
2012: Steven A Narod
Ten types of breast cancer?
Lancet 2012;380(9849):1212-3.
2012: Joanne Kotsopoulos; John R McLaughlin; Joel R K Moody; Harvey A Risch; Barry Rosen; Ping Sun; Isabel Fan; Steven A Narod
Height, weight, BMI and ovarian cancer survival.
Gynecologic oncology 2012;127(1):83-7.
2012: Amy Finch; Gareth Evans; Steven A Narod
BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.
Women's health (London, England) 2012;8(5):543-55.
2012: Joanne Kotsopoulos; Young-In Kim; Steven A Narod
Folate and breast cancer: what about high-risk women?
Cancer causes & control : CCC 2012;23(9):1405-20.
2012: Mohammad R Akbari; Robert Bristow; Justin Lee; Andrew Loblaw; Steven A Narod; Stephanie Tam; John Trachtenberg; Robert K Nam
Association between germline HOXB13 G84E mutation and risk of prostate cancer.
Journal of the National Cancer Institute 2012;104(16):1260-2.
2012: Steven A Narod
Breast cancer in young women.
Nature reviews. Clinical oncology 2012;9(8):460-70.
2012: Robert K Nam; Lesley K Carr; Sender Herschorn; Laurence H Klotz; Ronald T Kodama; Calvin H L Law; Ying Liu; D Andrew Loblaw; Refik Saskin; Aleksandra Stanimirovic; David R Urbach; Vasundara Venkateswaran; Steven A Narod
Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer.
The Journal of urology 2012;188(2):502-6.
2012: Steven A Narod; Sharon Nofech-Mozes; Ping Sun; A Valentini; Wedad M Hanna
Tumour characteristics among women with very low-risk breast cancer.
Breast cancer research and treatment 2012;134(3):1241-6.
2012: Steven A Narod
Supplementary imaging for breast cancer screening in high-risk women.
JAMA : the journal of the American Medical Association 2012;308(3):236; author reply 236-7.
2012: Joanne Kotsopoulos; Magdalena Muszyńska; Steven A Narod; Ryszard Oliński; Małgorzata Stawicka; Grzegorz Sukiennicki; Aleksandra Tołoczko-Grabarek; Oleg Ashuryk; Tomasz Byrski; Tadeusz Dębniak; Katarzyna Durda; Daniel Gackowski; D Godlewski; Jacek Gronwald; Tomasz Huzarski; Anna Jakubowska; Katarzyna Jaworska; Krzysztof Kąklewski; Jan Lubinski
Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study.
Cancer causes & control : CCC 2012;23(7):1065-74.
2012: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Susan L Neuhausen; Leigha Senter; Christian Singer; Ping Sun; Nadine Tung; Jeffrey Weitzel; Dana Zakalik; Peter Ainsworth; Joanne L Blum; Rochelle Demsky; Andrea Eisen; Charis Eng; Taya Fallen; William D Foulkes; Parviz Ghadirian; Dawna M Gilchrist; Ophira Ginsburg; Tomasz Huzarski; Beth Karlan; Charmaine Kim-Sing; Steven A Narod
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(7):1089-96.
2012: Jan Lubinski; Henry T Lynch; Steven A Narod; Susan L Neuhausen; M Stawicka; Ping Sun; Kevin Sweet; Susan Armel; Tomasz Byrski; Cezary Cybulski; Andrea Eisen; William D Foulkes; Parviz Ghadirian; Dawna Gilchrist; Bohdan Gorski; Jacek Gronwald; Tomasz Huzarski; Ewa Kilar; Charmaine Kim-Sing
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland.
International journal of cancer. Journal international du cancer 2012;131(1):229-34.
2012: K Passaperuma; Donald B Plewes; Elizabeth A Ramsay; Rene S Shumak; L Verity; Ellen Warner; John Wong; Frances C Wright; Martin J Yaffe; S Balasingham; Petrina A Causer; B Curpen; A Eisen; K A Hill; Roberta A Jong; S Messner; Steven A Narod
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
British journal of cancer 2012;107(1):24-30.
2012: Jacob McGee; Steven A Narod; Barry Rosen; Leigha Senter; Ping Sun; Nadine Tung; Peter Ainsworth; Andrea Eisen; William D Foulkes; Parviz Ghadirian; Beth Karlan; Charmaine Kim-Sing; Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch
Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers.
Obesity (Silver Spring, Md.) 2012;20(6):1288-92.
2012: Kelly A Metcalfe; Nida Mian; Sonia Nanda; Melissa Enmore; Kevin S Hughes; Marcia Llacuachaqui; Aletta Poll; Ping Sun; Steven A Narod
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
Breast cancer research and treatment 2012;133(2):735-40.
2012: Javaid Iqbal; Gareth Evans; Ophira M Ginsburg; Anthony Howell; Ivana Sestak; Thiwanka D Wijeratne; Steven A Narod
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.
Cancer treatment reviews 2012;38(4):318-28.
2012: Eileen Rakovitch; Refik Saskin; Jacqueline Spayne; C Taylor; D Thiruchelvam; Wedad M Hanna; Steven A Narod; Sharon Nofech-Mozes; Lawrence Paszat
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
British journal of cancer 2012;106(6):1160-5.
2012: Kristen N Stevens; Rebecca Sutphen; Ya-Yu Tsai; Robert A Vierkant; Xianshu Wang; Sebastian M Armasu; Andrew Berchuck; Michael J Birrer; Zachary S Fredericksen; Brooke L Fridley; Ellen L Goode; Linda E Kelemen; Steven A Narod; Catherine M Phelan; Joellen M Schildkraut; Thomas A Sellers; Fergus J Couch
Common variation in Nemo-like kinase is associated with risk of ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(3):523-8.
2012: Alexandra Ortiz Rodríguez; Robert Royer; Jeffrey N Weitzel; Garrett Larson; Marcia Llacuachaqui; Gonzalo Guevara Pardo; Steven A Narod
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Gynecologic oncology 2012;124(2):236-43.
2012: Magda Cb Gomes; Joanne Kotsopoulos; Mauricio M Costa; Gutemberg Leão de Almeida; Paulo Roberto F Leal; Firmino de Ag Filho; Marcos B Pitombo; Robert Royer; Roberto Vieira; Phil Zhang; Steven A Narod
The R337H mutation in TP53 and breast cancer in Brazil.
Hereditary cancer in clinical practice 2012;10(1):3.
2012: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Steven A Narod; Susan L Neuhausen; Aletta Poll; Leonardo Salmena; Leigha Senter; Christian Singer; Ping Sun; Nadine Tung; Peter Ainsworth; Joanne Blum; Rochelle Demsky; Andrea Eisen; Charis Eng; William D Foulkes; Parviz Ghadirian; Ophira Ginsburg; Tomasz Huzarski; Charmaine Kim-Sing
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast cancer research : BCR 2012;14(2):R42.
2011: Robert K Nam; Michael W Kattan; Laurence H Klotz; D Andrew Loblaw; Yan Lu; David Malkin; Arun Seth; Adam Shlien; Katherine Siminovitch; Aleksandra Stanimirovic; Linda Sugar; Ants Toi; John Trachtenberg; Vasundara Venkateswaran; Changhong Yu; Jinyi Zhang; William Zhang; Steven A Narod
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
Cancer biology & therapy 2011;12(11):997-1004.
2011: Steven A Narod
Alcohol and risk of breast cancer.
JAMA : the journal of the American Medical Association 2011;306(17):1920-1.
2011: Steven A Narod; Leonardo Salmena
BRCA1 and BRCA2 mutations and breast cancer.
Discovery medicine 2011;12(66):445-53.
2011: Mohammad R Akbari; Isabel Fan; Song Li; John McLaughlin; Harvey Risch; Barry Rosen; Robert Royer; Ping Sun; Shiyu Zhang; Steven A Narod
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes.
Journal of medical genetics 2011;48(11):783-6.
2011: Amy Finch; Steven A Narod
Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Maturitas 2011;70(3):261-5.
2011: Steven A Narod
Hormone replacement therapy and the risk of breast cancer.
Nature reviews. Clinical oncology 2011;8(11):669-76.
2011: Cezary Cybulski; Tadeusz Deebniak; Bohdan Górski; Jacek Gronwald; Tomasz Huzarski; Anna Jakubowska; Steven A Narod; Paweł Blecharz; Tomasz Byrski; Bartlomiej Masojc; Dominika Wokolorczyk; Jan Lubinski
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(28):3747-52.
2011: Steven A Narod
Screening of women at high risk for breast cancer.
Preventive medicine 2011;53(3):127-30.
2011: Steven A Narod; Javaid Iqbal
Tamoxifen chemoprevention and cardiac disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):3106-7; author reply 3107.
2011: Susan L Neuhausen; Olufunmilayo I Olopade; Georg Pfeiler; Timothy R Rebbeck; Wendy S Rubinstein; Christian F Singer; Linda Steele; Gail Tomlinson; Nadine Tung; Jeffrey N Weitzel; Joanne L Blum; Sean Brummel; Fergus Couch; Mary B Daly; Yuan Chun Ding; Susan Domchek; Patricia A Ganz; Judy E Garber; Andrew Godwin; Claudine Isaacs; Henry T Lynch; Steven A Narod; Katherine L Nathanson; Daniel L Gillen
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(8):1690-702.
2011: Robert K Nam; David Bell; Joseph L Chin; Eleftherios P Diamandis; Jonathan Izawa; Michael W Kattan; Laurence H Klotz; D Andrew Loblaw; Ricardo Rendon; Christopher Sherman; Rajiv Singal; Aleksandra Stanimirovic; Linda Sugar; John Trachtenberg; Vasundara Venkateswaran; Changhong Yu; Steven A Narod
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):2959-64.
2011: Steven A Narod
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
Breast cancer research and treatment 2011;128(2):581-3.
2011: Steven A Narod
Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening.
Breast cancer research and treatment 2011;128(1):259-66.
2011: Jennifer Permuth-Wey; Catherine M Phelan; Xiaotao Qu; Harvey Risch; Joellen M Schildkraut; Heather Stockwell; Rebecca Sutphen; Ya-Yu Tsai; Robert A Vierkant; Jill Barnholtz-Sloan; Y Ann Chen; Zhihua Chen; Julie M Cunningham; Getachew Dagne; David Fenstermacher; Brooke L Fridley; Ellen L Goode; Edwin Iversen; Johnathan M Lancaster; John McLaughlin; Steven A Narod; Thomas A Sellers
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(6):1131-45.
2011: Leonid Raskin; Gad Rennert; F Schwenter; Stephen N Thibodeau; M Tischkowitz; N Wong; M Aronson; F Bogomolniy; G Chong; M Freytsis; S Gallinger; Stephen B Gruber; K S Hunt; Deborah Levine; Steven A Narod; W D Foulkes
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome.
Clinical genetics 2011;79(6):512-22.
2011: Steven A Narod
Genetic variants associated with breast-cancer risk.
The lancet oncology 2011;12(5):415-6.
2011: Louise Bordeleau; Lorraine Lipscombe; Jan Lubinski; Parviz Ghadirian; William D Foulkes; Susan Neuhausen; Peter Ainsworth; Michael Pollak; Ping Sun; Steven A Narod
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations.
Cancer 2011;117(9):1812-8.
2011: Ellen Warner; Kimberley Hill; Petrina Causer; Donald Plewes; Roberta Jong; Martin Yaffe; William D Foulkes; Parviz Ghadirian; Henry Lynch; Fergus Couch; John Wong; Frances Wright; Ping Sun; Steven A Narod
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(13):1664-9.
2011: Shiyu Zhang; Robert Royer; Song Li; John R McLaughlin; Barry Rosen; Harvey A Risch; Isabel Fan; Linda Bradley; PA Shaw; Steven A Narod
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Gynecologic oncology 2011;121(2):353-7.
2011: Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Mutations in Fanconi anemia genes and the risk of esophageal cancer.
Human genetics 2011;129(5):573-82.
2011: Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Charmaine Kim-Sing; Olufunmilayo I Olopade; Susan M Domchek; Andrea Eisen; William D Foulkes; Barry Rosen; Danny Vesprini; Ping Sun; Steven A Narod
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2011;127(1):287-96.
2011: Kelly A Metcalfe; S Gershman; Henry T Lynch; Parviz Ghadirian; N Tung; Charmaine Kim-Sing; Olufunmilayo I Olopade; Susan M Domchek; J McLennan; A Eisen; William D Foulkes; Barry Rosen; Ping Sun; Steven A Narod
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
British journal of cancer 2011;104(9):1384-92.
2011: Danny Vesprini; Steven A Narod; John Trachtenberg; Juanita Crook; Farid Jalali; John Preiner; Srikala Sridhar; Robert G Bristow
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(2):E31-5.
2011: A Finch; Kelly A Metcalfe; J K Chiang; L Elit; J McLaughlin; C Springate; R Demsky; J Murphy; B Rosen; Steven A Narod
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
Gynecologic oncology 2011;121(1):163-8.
2011: Ofer Lavie; Steven A Narod; Flavio Lejbkowicz; Sara Dishon; Y Goldberg; O Gemer; Gad Rennert
Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):964-6.
2011: Nancy Hamel; Bing-Jian Feng; Lenka Foretova; Dominique Stoppa-Lyonnet; Steven A Narod; Evgeny Imyanitov; Olga Sinilnikova; Laima Tihomirova; Jan Lubinski; Jacek Gronwald; Bohdan Gorski; Finn C Nielsen; Mads Thomassen; Drakoulis Yannoukakos; Irene Konstantopoulou; Vladimir Zajac; Sona Ciernikova; Fergus J Couch; Celia M T Greenwood; David E Goldgar; Thomas v O Hansen; William D Foulkes
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
European journal of human genetics : EJHG 2011;19(3):300-6.
2011: Ellen Warner; Petrina A Causer; John Wong; Frances C Wright; Roberta A Jong; Kimberley A Hill; Sandra J Messner; Martin J Yaffe; Steven A Narod; Donald B Plewes
Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
The breast journal 2011;17(1):9-17.
2011: Talia Donenberg; John Lunn; Duvaughn Curling; Theodore Turnquest; Elisa Krill-Jackson; Robert Royer; Steven A Narod; Judith Hurley DeLeo
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Breast cancer research and treatment 2011;125(2):591-6.
2010: Kelly A Metcalfe; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; William D Foulkes; Charmaine Kim-Sing; Susan Neuhausen; Nadine Tung; Barry Rosen; Jacek Gronwald; Peter Ainsworth; Kevin Sweet; Andrea Eisen; Ping Sun; Steven A Narod
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
Journal of the National Cancer Institute 2010;102(24):1874-8.
2010: Steven A Narod
BRCA mutations in the management of breast cancer: the state of the art.
Nature reviews. Clinical oncology 2010;7(12):702-7.
2010: Janina Suchy; Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Tadeusz Dębniak; Jacek Gronwald; Anna Jakubowska; Dominika Wokołorczyk; Grzegorz Kurzawski; Józef Kładny; Arkadiusz Jawień; Zbigniew Banaszkiewicz; Rafał Wiśniowski; Piotr Wandzel; Jacek Starzewski; Zbigniew Lorenc; Elżbieta Korobowicz; Piotr Krokowicz; Karolina Horbacka; Jan Lubiński; Steven A Narod
BRCA1 mutations and colorectal cancer in Poland.
Familial cancer 2010;9(4):541-4.
2010: Ophira M Ginsburg; Charmaine Kim-Sing; William D Foulkes; Parviz Ghadirian; Henry T Lynch; Ping Sun; Steven A Narod
BRCA1 and BRCA2 families and the risk of skin cancer.
Familial cancer 2010;9(4):489-93.
2010: Steven A Narod
Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):e698-9; author reply e700.
2010: Danielle Vicus; PA Shaw; Amy Finch; Barry Rosen; Joan Murphy; Susan Armel; Ping Sun; Steven A Narod
Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers.
Gynecologic oncology 2010;118(3):295-8.
2010: Danielle Vicus; Amy Finch; Ilana Cass; Barry Rosen; Joan Murphy; Isabel Fan; Robert Royer; John McLaughlin; Beth Karlan; Steven A Narod
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
Gynecologic oncology 2010;118(3):299-302.
2010: Danielle Vicus; Amy Finch; Barry Rosen; Isabel Fan; Linda Bradley; Ilana Cass; Ping Sun; Beth Y Karlan; John McLaughlin; Steven A Narod
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
Gynecologic oncology 2010;118(2):155-9.
2010: Steven A Narod
Screening of women at high familial risk of breast cancer.
Women's health (London, England) 2010;6(4):509-10.
2010: Steven A Narod
Genes, the environment, and breast cancer.
Lancet 2010;375(9732):2123-4.
2010: Janina Suchy; Cezary Cybulski; Dominika Wokołorczyk; Oleg Oszurek; Bohdan Górski; Tadeusz Debniak; Anna Jakubowska; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Ireneusz Dziuba; Marek Gogacz; Rafał Wiśniowski; Piotr Wandzel; Zbigniew Banaszkiewicz; Grzegorz Kurzawski; Józef Kładny; Steven A Narod; Jan Lubiński
CHEK2 mutations and HNPCC-related colorectal cancer.
International journal of cancer. Journal international du cancer 2010;126(12):3005-9.
2010: William D Foulkes; Jorge S Reis-Filho; Steven A Narod
Tumor size and survival in breast cancer--a reappraisal.
Nature reviews. Clinical oncology 2010;7(6):348-53.
2010: Joanne Kotsopoulos; Zhou Chen; Katherine A Vallis; Aletta Poll; Parviz Ghadirian; Greg Kennedy; Peter Ainsworth; Steven A Narod
Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers.
Cancer causes & control : CCC 2010;21(5):679-87.
2010: Tuya Pal; David Keefe; Ping Sun; Steven A Narod
Fertility in women with BRCA mutations: a case-control study.
Fertility and sterility 2010;93(6):1805-8.
2010: Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
The Journal of urology 2010;183(3):963-8.
2010: S Panchal; L Bordeleau; A Poll; M Llacuachaqui; O Shachar; P Ainsworth; S Armel; A Eisen; P Sun; Steven A Narod
Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation-positive families?
Clinical genetics 2010;77(3):273-9.
2010: Dominika Wokołorczyk; Bartlomiej Gliniewicz; Marcin Stojewski; Andrzej Sikorski; Elibieta Złowocka; Tadeusz Debniak; Anna Jakubowska; Bohdan Górski; Thierry van de Wetering; Steven A Narod; Jan Lubiński; Cezary Cybulski
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2010;19(2):167-71.
2010: Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):387-91.
2010: M Yaghoobi; R Bijarchi; Steven A Narod
Family history and the risk of gastric cancer.
British journal of cancer 2010;102(2):237-42.
2010: Núria Bonifaci; Bohdan Górski; Bartlomiej Masojć; Dominika Wokołorczyk; Anna Jakubowska; Tadeusz Dębniak; Antoni Berenguer; Jordi Serra Musach; Joan Brunet; Joaquín Dopazo; Steven A Narod; Jan Lubiński; Conxi Lázaro; Cezary Cybulski; Miguel Angel Pujana
Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.
PloS one 2010;5(11):e14078.
2010: Mark J Lim; Heather P Ostendorff; Steven A Narod; Gabriel J Foster; Sadanand Gite; Kenneth Rothschild
An ELISA-based high throughput protein truncation test for inherited breast cancer.
Breast cancer research : BCR 2010;12(5):R78.
2010: Mohammad R Akbari; Patricia Tonin; William D Foulkes; Parviz Ghadirian; Marc Tischkowitz; Steven A Narod
RAD51C germline mutations in breast and ovarian cancer patients.
Breast cancer research : BCR 2010;12(4):404.
2009: tulin cil; Eve Fishell; Wedad Hanna; Ping Sun; Ellen Rawlinson; Steven A Narod; David R McCready
Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery.
Cancer 2009;115(24):5780-7.
2009: Parviz Ghadirian; André Robidoux; P Zhang; R Royer; M Akbari; S Zhang; E Fafard; M Costa; G Martin; C Potvin; E Patocskai; N Larouche; R Younan; E Nassif; Sylvie Giroux; Steven A Narod; Francois Rousseau; William D Foulkes
The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
Clinical genetics 2009;76(5):421-6.
2009: Lili Li; Kajal Biswas; Laura Anne Habib; Sergey G Kuznetsov; Nancy Hamel; Tomas Kirchhoff; Nora Wong; Susan Armel; George Chong; Steven A Narod; Kathleen Claes; Kenneth Offit; Mark Robson; Stacey Stauffer; Shyam K Sharan; William D Foulkes
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant.
Human mutation 2009;30(11):1543-50.
2009: Rebecca Dent; Wedad M Hanna; Maureen Trudeau; Ellen Rawlinson; Ping Sun; Steven A Narod
Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
Cancer 2009;115(21):4917-23.
2009: Sharon Nofech-Mozes; Maureen Trudeau; Harriet K Kahn; Rebecca Dent; Ellen Rawlinson; Ping Sun; Steven A Narod; Wedad M Hanna
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.
Breast cancer research and treatment 2009;118(1):131-7.
2009: Mohammad Reza Akbari; Reza Malekzadeh; Ramin Shakeri; dariush nasrollahzadeh; Maryam Foumani; Yulong Sun; Akram Pourshams; Alireza Sadjadi; Elham Jafari; Masoud Sotoudeh; Farin Kamangar; Paolo Boffetta; Sanford M Dawsey; Parviz Ghadirian; Steven A Narod
Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran.
Cancer research 2009;69(20):7994-8000.
2009: Danielle Vicus; Barry Rosen; Jan Lubinski; Susan Domchek; Noah D Kauff; Henry T Lynch; Claudine Isaacs; Nadine Tung; Ping Sun; Steven A Narod
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.
Gynecologic oncology 2009;115(1):135-7.
2009: Henry T Lynch; Carrie L Snyder; Jane F Lynch; Sumedha Ghate; Steven A Narod; Gordon Gong
Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutations.
The breast journal 2009;15 Suppl 1():S20-4.
2009: Pablo Serrano-Fernández; Tadeusz Debniak; Bohdan Górski; Natalia Bogdanova; Thilo Dörk; Cezary Cybulski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Dominika Wokołorczyk; Steven A Narod; Jan Lubiński
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Breast cancer research and treatment 2009;117(1):161-5.
2009: Timothy R Rebbeck; Nandita Mitra; Susan M Domchek; Fei Wan; Shaokun Chuai; Tara Friebel; Saarene Panossian; Amanda Spurdle; Georgia Chenevix-Trench; Christian F Singer; Georg Pfeiler; Susan L Neuhausen; Henry T Lynch; Judy E Garber; Jeffrey N Weitzel; Claudine Isaacs; Fergus J. Couch; Steven A Narod; Wendy S Rubinstein; Gail Tomlinson; Patricia Anne Ganz; Olufunmilayo I Olopade; Nadine Tung; Joanne L Blum; Roger A. Greenberg; Katherine L Nathanson; Mary B Daly
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Cancer research 2009;69(14):5801-10.
2009: Sławomir Ertmański; Kelly Metcalfe; Janusz Trempała; Maria Danuta Głowacka; Jan Lubiński; Steven A Narod; Jacek Gronwald
Identification of patients at high risk of psychological distress after BRCA1 genetic testing.
Genetic testing and molecular biomarkers 2009;13(3):325-30.
2009: Jacek Gronwald; Cezary Cybulski; W Piesiak; Janina Suchy; Tomasz Huzarski; Tomasz Byrski; Bohdan Gorski; Tadeusz Debniak; Marek Szwiec; D Wokolowczyk; M Matuszewski; Ping Sun; Jan Lubinski; Steven A Narod
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.
British journal of cancer 2009;100(9):1508-12.
2009: Tomasz Byrski; Tomasz Huzarski; R Dent; Jacek Gronwald; D Zuziak; Cezary Cybulski; Józef Kladny; Bohdan Gorski; Jan Lubinski; Steven A Narod
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.
Breast cancer research and treatment 2009;115(2):359-63.
2009: Rebecca Dent; Wedad M Hanna; Maureen Trudeau; Ellen Rawlinson; Ping Sun; Steven A Narod
Pattern of metastatic spread in triple-negative breast cancer.
Breast cancer research and treatment 2009;115(2):423-8.
2009: Mario E Beiner; William W Zhang; Shiyu Zhang; Steven Gallinger; Ping Sun; Steven A Narod
Mutations of the MYH gene do not substantially contribute to the risk of breast cancer.
Breast cancer research and treatment 2009;114(3):575-8.
2009: A Finch; K Metcalfe; J Lui; C Springate; R Demsky; S Armel; B Rosen; J Murphy; L Elit; P Sun; Steven A Narod
Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.
Clinical genetics 2009;75(3):220-4.
2009: Robert K Nam; William W Zhang; John Trachtenberg; Arun Seth; Laurence H Klotz; Aleksandra Stanimirovic; Sanoj Punnen; Vasundara Venkateswaran; Ants Toi; D Andrew Loblaw; Linda Sugar; Katherine A Siminovitch; Steven A Narod
Utility of incorporating genetic variants for the early detection of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(5):1787-93.
2009: Anna Jakubowska; Katarzyna Jaworska; Cezary Cybulski; Anna Janicka; Jolanta Szymańska-Pasternak; Marcin Lener; Steven A Narod; Jan Lubiński
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
European journal of cancer (Oxford, England : 1990) 2009;45(5):837-42.
2009: Ophira Ginsburg; Parviz Ghadirian; Jan Lubinski; Cezary Cybulski; Henry Lynch; Susan Neuhausen; Charmaine Kim-Sing; Mark Robson; Susan Domchek; Claudine Isaacs; Jan Klijn; Susan Armel; William D Foulkes; Nadine Tung; Pal Moller; Ping Sun; Steven A Narod
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Breast cancer research and treatment 2009;114(1):127-35.
2009: Dominika Wokołorczyk; Jan Lubiński; Steven A Narod; Cezary Cybulski
Genetic heterogeneity of 8q24 region in susceptibility to cancer.
Journal of the National Cancer Institute 2009;101(4):278-9.
2009: Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Tadeusz Debniak; Dominika Wokolorczyk; Anna Jakubowska; Pablo Serrano-Fernández; T Dork; Steven A Narod; Jan Lubinski
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Journal of medical genetics 2009;46(2):132-5.
2009: Kelly A Metcalfe; A Finch; A Poll; Douglas E Horsman; Charmaine Kim-Sing; J Scott; R Royer; Ping Sun; Steven A Narod
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.
British journal of cancer 2009;100(2):421-5.
2009: Steven A Narod
Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective.
Salud pública de México 2009;51 Suppl 2():s191-6.
2009: Susan L Neuhausen; Sean Brummel; Yuan-Chun Ding; Christian F Singer; Georg Pfeiler; Henry T Lynch; Katherine L Nathanson; Timothy R Rebbeck; Judy E Garber; Fergus Couch; Jeffrey Weitzel; Steven A Narod; Patricia Anne Ganz; Mary B Daly; Andrew K Godwin; Claudine Isaacs; Olufunmilayo I Olopade; Gail Tomlinson; Wendy S Rubinstein; Nadine Tung; Joanne L Blum; Daniel L Gillen
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
Breast cancer research : BCR 2009;11(5):R76.
2009: Ophira M Ginsburg; Mohammad R Akbari; Zeba Aziz; Robert Young; Henry Lynch; Parviz Ghadirian; Andre Robidoux; Julian Londono; Gonzalo Vasquez; Magda Gomes; Mauricio Magalhaes Costa; Constantine Dimitrakakis; Gustavo Gutierrez; Robert Pilarski; Robert Royer; Steven A Narod
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30.
Familial cancer 2009;8(4):563-7.
2009: Yaakov Bentov; Theodore J Brown; Mohammad Reza Akbari; Robert Royer; Harvey A Risch; Barry Rosen; John McLaughlin; Ping Sun; Shiyu Zhang; Steven A Narod; Robert F Casper
Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.
PloS one 2009;4(6):e5918.
2009: S Robert Young; Robert T Pilarski; Talia Donenberg; Charles Shapiro; Lyn S Hammond; Judith Miller; Karen A. Brooks; Stephanie Cohen; Beverly Tenenholz; Damini Desai; Inuk Zandvakili; Robert Royer; Song Li; Steven A Narod
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
BMC cancer 2009;9():86.
2009: Veronica Wendy Setiawan; Jennifer A Doherty; Xiao-Ou Shu; Mohammad R Akbari; Chu Chen; Immaculata DeVivo; Angela Demichele; Montserrat Garcia-Closas; Marc T Goodman; Christopher A Haiman; Susan E Hankinson; Brian Henderson; Pamela L Horn-Ross; James V Lacey; Loïc Le Marchand; Douglas A Levine; Xiaolin Liang; Jolanta Lissowska; Galina Lurie; Monica McGrath; Steven A Narod; Timothy R Rebbeck; Giske Ursin; Noel S Weiss; Yong-Bing Xiang; Hannah P Yang; Wei Zheng; Sara H Olson
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):242-7.
2009: Cezary Cybulski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Tadeusz Debniak; Anna Jakubowska; Bohdan Górski; D Wokołorczyk; B Masojć; Steven A Narod; J Lubiński
Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.
Clinical genetics 2009;75(1):72-8.
2009: Mohammad Reza Akbari; Parviz Ghadirian; Andre Robidoux; Maryam Foumani; Yulong Sun; Robert Royer; Inuk Zandvakili; Henry Lynch; Steven A Narod
Germline RAP80 mutations and susceptibility to breast cancer.
Breast cancer research and treatment 2009;113(2):377-81.
2008: Dominika Wokolorczyk; Bartlomiej Gliniewicz; Andrzej Sikorski; Elzbieta Zlowocka; Bartlomiej Masojc; Tadeusz Debniak; Joanna Matyjasik; Marek Mierzejewski; Krzysztof Medrek; Dorota Oszutowska; Janina Suchy; Jacek Gronwald; Urszula Teodorczyk; Tomasz Huzarski; Tomasz Byrski; Anna Jakubowska; Bohdan Górski; Thierry van de Wetering; Swietlana Walczak; Steven A Narod; Jan Lubinski; Cezary Cybulski
A range of cancers is associated with the rs6983267 marker on chromosome 8.
Cancer research 2008;68(23):9982-6.
2008: Christine S Walsh; Seishi Ogawa; Daniel R Scoles; Carl W Miller; Norihiko Kawamata; Steven A Narod; H Phillip Koeffler; Beth Y Karlan
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7645-51.
2008: Joanne Kotsopoulos; Clifford L Librach; Jan Lubinski; Jacek Gronwald; Charmaine Kim-Sing; Parviz Ghadirian; Henry T Lynch; Pal Moller; William D Foulkes; Susan Randall; Siranoush Manoukian; Barbara Pasini; Nadine Tung; Peter Ainsworth; Shelly Cummings; Ping Sun; Steven A Narod
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Cancer causes & control : CCC 2008;19(10):1111-9.
2008: Jacek Gronwald; Anouk Pijpe; Tomasz Byrski; Tomasz Huzarski; M Stawicka; Cezary Cybulski; Flora van Leeuwen; Jan Lubiński; Steven A Narod
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.
Breast cancer research and treatment 2008;112(3):581-4.
2008: Joanne Kotsopoulos; William W Zhang; Shiyu Zhang; David R McCready; Maureen Trudeau; Phil Zhang; Ping Sun; Steven A Narod
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
Breast cancer research and treatment 2008;112(3):585-93.
2008: Cezary Cybulski; Dominika Wokołorczyk; Brtłomiej Gliniewicz; Andrzej Sikorski; Bohdan Górski; Anna Jakubowska; Tomasz Huzarski; Tomasz Byrski; Tadeusz Debniak; Jacek Gronwald; Jan Lubiński; Steven A Narod
A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population.
Breast cancer research and treatment 2008;112(2):367-8.
2008: Ewa Jaworowska; Pablo Serrano-Fernández; Czeslawa Tarnowska; Jakub Lubiński; Marek Brzosko; Jacek Flicinski; Bartlomiej Masojc; Joanna Matyjasik; Rodney J Scott; Steven A Narod; Jan Lubiński
Familial association of laryngeal, lung, stomach and early-onset breast cancer.
Breast cancer research and treatment 2008;112(2):359-61.
2008: Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen Cooney; Janet L Stanford; William D Foulkes
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.
Cancer letters 2008;270(1):173-80.
2008: Andrea Eisen; Jan Lubinski; Jacek Gronwald; Pal Moller; Henry T Lynch; Jan Klijn; Charmaine Kim-Sing; Susan L Neuhausen; Lucy Gilbert; Parviz Ghadirian; Siranoush Manoukian; Gad Rennert; Eitan Friedman; Claudine Isaacs; Eliot Rosen; Barry Rosen; Mary Daly; Ping Sun; Steven A Narod
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Journal of the National Cancer Institute 2008;100(19):1361-7.
2008: Steven A Narod; Arun Seth; Robert K Nam
Fusion in the ETS gene family and prostate cancer.
British journal of cancer 2008;99(6):847-51.
2008: Tuya Pal; Susan T Vadaparampil; Judy Betts; Cheryl Miree; Song Li; Steven A Narod
BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.
Genetic testing 2008;12(3):401-7.
2008: Steven A Narod; Susan L Neuhausen; G Vichodez; S Armel; Henry T Lynch; Parviz Ghadirian; S Cummings; Olufunmilayo I Olopade; D Stoppa-Lyonnet; Fergus J. Couch; T Wagner; Ellen Warner; William D Foulkes; Howard M Saal; Jeffrey N Weitzel; A Tulman; A Poll; R Nam; P Sun; Jessica Danquah; Susan Domchek; Nadine Tung; Peter Ainsworth; Douglas Horsman; Charmaine Kim-Sing; Christine Maugard; Andrea Eisen; Mary Daly; Wendy McKinnon; Marie Wood; Claudine Isaacs; Dawna Gilchrist; Beth Y Karlan; Raluca Nedelcu; Wendy Meschino; Judy Garber; Barbara Pasini; Siranoush Manoukian; Christina Bellati
Rapid progression of prostate cancer in men with a BRCA2 mutation.
British journal of cancer 2008;99(2):371-4.
2008: Ian Harley; Barry Rosen; Harvey A Risch; Kathy Siminovitch; Mario E Beiner; John McLaughlin; Ping Sun; Steven A Narod
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
Gynecologic oncology 2008;109(3):384-7.
2008: Kelly A Metcalfe; William D Foulkes; Charmaine Kim-Sing; P Ainsworth; Barry Rosen; S Armel; A Poll; Andrea Eisen; D Gilchrist; A Chudley; Parviz Ghadirian; C Maugard; E G Lemire; Ping Sun; Steven A Narod
Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
Clinical genetics 2008;73(5):474-9.
2008: Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan M Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus J. Couch; Ping Sun; Steven A Narod
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
International journal of cancer. Journal international du cancer 2008;122(9):2017-22.
2008: Shiyu Zhang; Catherine M Phelan; Phil Zhang; Francois Rousseau; Parviz Ghadirian; Andre Robidoux; William Foulkes; Nancy Hamel; David McCready; Maureen Trudeau; Henry Lynch; Douglas Horsman; Maria Lourdes Leon De Matsuda; Zeba Aziz; Magda Gomes; Mauricio Magalhaes Costa; Alexander Liede; Aletta Poll; Ping Sun; Steven A Narod
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.
Cancer research 2008;68(7):2154-7.
2008: Cezary Cybulski; Bartlomiej Masojc; Dorota Oszutowska; Ewa Jaworowska; Tomasz Grodzki; Piotr Waloszczyk; Piotr Serwatowski; Juliusz Pankowski; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Anna Jakubowska; Tadeusz Debniak; Dominika Wokolorczyk; Jacek Gronwald; Czeslawa Tarnowska; Pablo Serrano-Fernández; Jan Lubinski; Steven A Narod
Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
Carcinogenesis 2008;29(4):762-5.
2008: Suzanna L Arcand; Christine M Maugard; Parviz Ghadirian; André Robidoux; Chantal Perret; Phil Zhang; Eve Fafard; Anne-Marie Mes-Masson; William D Foulkes; Diane Provencher; Steven A Narod; Patricia N Tonin
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Breast cancer research and treatment 2008;108(3):399-408.
2008: Rachel Z Bigenwald; Ellen Warner; Anoma Gunasekara; Kimberley A Hill; Petrina A Causer; Sandra J Messner; Andrea Eisen; Donald B Plewes; Steven A Narod; Liying Zhang; Martin J Yaffe
Is mammography adequate for screening women with inherited BRCA mutations and low breast density?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(3):706-11.
2008: Kelly A Metcalfe; Jan Lubinski; Parviz Ghadirian; Henry Lynch; Charmaine Kim-Sing; Eitan Friedman; William D Foulkes; Susan M Domchek; Peter Ainsworth; Claudine Isaacs; Nadine Tung; Jacek Gronwald; Shelly Cummings; Teresa Wagner; Siranoush Manoukian; Pål Møller; Jeffrey N Weitzel; Ping Sun; Steven A Narod
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1093-7.
2008: Tomasz Byrski; Jacek Gronwald; Tomasz Huzarski; E Grzybowska; M Budryk; M Stawicka; T Mierzwa; Marek Szwiec; R Wiśniowski; M Siolek; Steven A Narod; Jan Lubinski
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers.
Breast cancer research and treatment 2008;108(2):289-96.
2008: Mohammad Reza Akbari; Reza Malekzadeh; dariush nasrollahzadeh; D Amanian; Farhad Islami; S Li; I Zandvakili; Ramin Shakeri; Masoud Sotoudeh; K Aghcheli; R Salahi; Akram Pourshams; Shahriar Semnani; Paolo Boffetta; Sanford M Dawsey; Parviz Ghadirian; Steven A Narod
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
Oncogene 2008;27(9):1290-6.
2008: Cezary Cybulski; Bohdan Górski; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Tadeusz Debniak; Anna Jakubowska; Dominika Wokołorczyk; Bartlomiej Gliniewicz; Andrzej Sikorski; M Stawicka; D Godlewski; Zbigniew Kwias; Andrzej Antczak; Kazimierz Krajka; Wojciech Lauer; Marek Sosnowski; Paulina Sikorska-Radek; Krzysztof Bar; Robert Klijer; Zdrojowy Romuald; Bartosz Małkiewicz; Andrzej Borkowski; Tomasz Borkowski; Marek Szwiec; Michal Posmyk; Steven A Narod; Jan Lubiński
BRCA1 mutations and prostate cancer in Poland.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2008;17(1):62-6.
2008: David J Novak; Long Qi Chen; Parviz Ghadirian; Nancy Hamel; Phil Zhang; Vanessa Rossiny; Guy Cardinal; André Robidoux; Patricia N Tonin; Francois Rousseau; Steven A Narod; William D Foulkes
Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women.
BMC cancer 2008;8():239.
2008: Rolando Comacho Rodriguez; Antonio Alejandro Esperon; Ramon Ropero; Maria Caridad Rubio; Ronald Rodriguez; Rosa M Ortiz; Juan J Lence Anta; Mario de los Rios; Deyanira Carnesolta; Maria C del Olivera; Somalia Stiu Vansam; Robert Royer; Mohammad R Akbari; Talia Donenberg; Steven A Narod
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba.
Familial cancer 2008;7(3):275-9.
2008: Robert K Nam; William W Zhang; D Andrew Loblaw; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; A Stanimirovic; T O Davies; Ants Toi; Vasundara Venkateswaran; Linda Sugar; Katherine A Siminovitch; Steven A Narod
A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Prostate cancer and prostatic diseases 2008;11(3):241-6.
2008: Anna Jakubowska; Cezary Cybulski; Anna Szymańska; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Tadeusz Debniak; Bohdan Górski; Elzbieta Kowalska; Steven A Narod; Jan Lubiński
BARD1 and breast cancer in Poland.
Breast cancer research and treatment 2008;107(1):119-22.
2007: Robert K Nam; Linda Sugar; W Yang; sudhir srivastava; Laurence H Klotz; L-Y Yang; A Stanimirovic; E Encioiu; M Neill; D Andrew Loblaw; John Trachtenberg; Steven A Narod; Arun Seth
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.
British journal of cancer 2007;97(12):1690-5.
2007: Eileen Rakovitch; Jean-Philippe Pignol; Wedad M Hanna; Steven A Narod; Jacqueline Spayne; Sharon Nofech-Mozes; Carole Chartier; Lawrence Paszat
Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5591-6.
2007: William Chu; Anthony Fyles; Edward M Sellers; David R McCready; Joan Murphy; Tuya Pal; Steven A Narod
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.
Carcinogenesis 2007;28(10):2139-42.
2007: Jan Lubinski; Marcin Korzen; Bohdan Gorski; Cezary Cybulski; Tadeusz Debniak; Anna Jakubowska; Krzysztof Medrek; Joanna Matyjasik; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Bartlomiej Masojc; Marcin Lener; Anna Szymanska; Jolanta Szymanska-Pasternak; Pablo Serrano Fernandez; Dominika Wokolorczyk; Andrzej Piegat; Michal Ucinski; Pawel Domagala; Józef Kladny; Barbara Gorecka; Rodney Scott; Steven A Narod
Breast cancer susceptibility genes.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12 Suppl 1():S23-9.
2007: Kelly A Metcalfe; A Poll; A O'Connor; S Gershman; S Armel; A Finch; R Demsky; Barry Rosen; Steven A Narod
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
Clinical genetics 2007;72(3):208-17.
2007: Robert K Nam; Ants Toi; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Sree Appu; D Andrew Loblaw; Linda Sugar; Steven A Narod; Michael W Kattan
Assessing individual risk for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3582-8.
2007: Erica Rowan; Aletta Poll; Steven A Narod
A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.
Journal of medical genetics 2007;44(8):e89; author reply e88.
2007: Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod
Triple-negative breast cancer: clinical features and patterns of recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4429-34.
2007: Gad Rennert; Shantih Bisland-Naggan; Ofra Barnett-Griness; Naomi Bar-Joseph; Shiyu Zhang; Hanna Rennert; Steven A Narod
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
The New England journal of medicine 2007;357(2):115-23.
2007: Magda C B Gomes; Mauricio M Costa; Radovan Borojevic; Alvaro Monteiro; Roberto Vieira; Sergio Koifman; Rosalina Jorge Koifman; Song Li; Robert Royer; Shiyu Zhang; Steven A Narod
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Breast cancer research and treatment 2007;103(3):349-53.
2007: Tadeusz Debniak; Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Anna Jakubowska; Elzbieta Kowalska; Oleg Oszurek; Steven A Narod; Jan Lubiński
CDKN2A-positive breast cancers in young women from Poland.
Breast cancer research and treatment 2007;103(3):355-9.
2007: George Zogopoulos; Heidi Rothenmund; Ayelet Eppel; Colleen Ash; Mohammad Reza Akbari; David Hedley; Steven A Narod; Steven Gallinger
The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
Human genetics 2007;121(5):635-7.
2007: Steven A Narod
Ovarian cancer and HRT in the Million Women Study.
Lancet 2007;369(9574):1667-8.
2007: Joanne Kotsopoulos; Parviz Ghadirian; Ahmed El-Sohemy; Henry T Lynch; Carrie Snyder; Mary Daly; Susan M Domchek; Susan Randall; Beth Y Karlan; Phil Zhang; Shiyu Zhang; Ping Sun; Steven A Narod
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):912-6.
2007: Marc Tischkowitz; Bing Xia; Nelly Sabbaghian; Jorge S Reis-Filho; Nancy Hamel; Guilan Li; erik van beers; Lili Li; Tayma Khalil; Louise A Quenneville; Atilla Omeroglu; Aletta Poll; Pierre Lepage; Nora Wong; petra nederlof; Alan Ashworth; Patricia N Tonin; Steven A Narod; David M Livingston; William D Foulkes
Analysis of PALB2/FANCN-associated breast cancer families.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(16):6788-93.
2007: Jacek Gronwald; Cezary Cybulski; Jan Lubinski; Steven A Narod
Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling.
Journal of medical genetics 2007;44(4):e76.
2007: Cezary Cybulski; Bartlomiej Gliniewicz; Andrzej Sikorski; Józef Kładny; Tomasz Huzarski; Jacek Gronwald; Tomasz Byrski; Tadeusz Debniak; Bohdan Gorski; Anna Jakubowska; Dominika Wokolorczyk; Steven A Narod; Jan Lubiñski
Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):572-6.
2007: Cezary Cybulski; Dominika Wokołorczyk; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Bohdan Górski; Tadeusz Debniak; Bartłomiej Masojć; Anna Jakubowska; Thierry van de Wetering; Steven A Narod; Jan Lubiński
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Breast cancer research and treatment 2007;102(1):119-22.
2007: Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Cezary Cybulski; M Stawicka; Marek Szwiec; Tadeusz Debniak; A Tulman; Ping Sun; Oleg Oszurek; Jan Lubinski; Steven A Narod
A survey of preventive measures among BRCA1 mutation carriers from Poland.
Clinical genetics 2007;71(2):153-7.
2007: Angel Arnaout-Alkarain; Harriette J Kahn; Steven A Narod; Ping A Sun; Alexander N Marks
Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(2):183-91.
2007: Cezary Cybulski; Dominika Wokołorczyk; Józef Kładny; Grzegorz Kurzawski; Grzegorz Kurzwaski; Janina Suchy; Ewa Grabowska; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Tadeusz D Ecedil Bniak; Steven A Narod; Jan Lubiński
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
European journal of human genetics : EJHG 2007;15(2):237-41.
2007: Isabel Chu; Jun Sun; Angel Arnaout; Harriette Kahn; Wedad Hanna; Steven A Narod; Ping Sun; Cheng-Keat Tan; Ludger Hengst; Joyce M Slingerland
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
Cell 2007;128(2):281-94.
2007: Joanne Kotsopoulos; Z Chen; K A Vallis; A Poll; Peter Ainsworth; Steven A Narod
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers.
British journal of cancer 2007;96(1):118-25.
2007: Kelly A Metcalfe; Steven A Narod
Breast cancer prevention in women with a BRCA1 or BRCA2 mutation.
Open medicine : a peer-reviewed, independent, open-access journal 2007;1(3):e184-90.
2007: Kelly A Metcalfe; Parviz Ghadirian; Barry P Rosen; William Foulkes; Charmaine Kim-Sing; Andrea Eisen; Peter Ainsworth; Doug Horsman; Christine Maugard; Diane Provencher; André Robideaux; Dawna Gilchrist; Albert Chudley; Edmond G Lemire; Susan Armel; Amy Finch; Ping Sun; Steven A Narod
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.
Open medicine : a peer-reviewed, independent, open-access journal 2007;1(2):e92-8.
2007: William D Foulkes; Parviz Ghadirian; Mohammed Reza Akbari; Nancy Hamel; Sylvie Giroux; Nelly Sabbaghian; Andrew Darnel; Robert Royer; Aletta Poll; Eve Fafard; André Robidoux; Ginette Martin; Tarek A Bismar; Marc Tischkowitz; Francois Rousseau; Steven A Narod
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
Breast cancer research : BCR 2007;9(6):R83.
2007: Cezary Cybulski; Dominika Wokołorczyk; Anna Jakubowska; Bartlomiej Gliniewicz; Andrzej Sikorski; Tomasz Huzarski; Tadeusz Debniak; Steven A Narod; Jan Lubiński
DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland.
Urologia internationalis 2007;79(1):44-9.
2007: John R McLaughlin; Harvey A Risch; Jan Lubinski; Pal Moller; Parviz Ghadirian; Henry T Lynch; Beth Y Karlan; David Fishman; Barry Rosen; Susan L Neuhausen; Kenneth Offit; Noah D Kauff; Susan M Domchek; Nadine Tung; Eitan Friedman; William D Foulkes; Ping Sun; Steven A Narod
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
The lancet oncology 2007;8(1):26-34.
2007: Robert K Nam; Linda Sugar; Zhenghui Wang; Wenyi Yang; Richard Kitching; Laurence H Klotz; Vasundara Venkateswaran; Steven A Narod; Arun Seth
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.
Cancer biology & therapy 2007;6(1):40-5.
2007: Steven A Narod; Henry T Lynch
CHEK2 mutation and hereditary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):6-7.
2007: Mario E Beiner; Amy Finch; Barry Rosen; Jan Lubinski; Pal Moller; Parviz Ghadirian; Henry T Lynch; Eitan Friedman; Ping Sun; Steven A Narod
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
Gynecologic oncology 2007;104(1):7-10.
2006: M Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bilal Naqvi; Abdul Rauf Shakoori; Antje Seidel-Renkert; Humirah Farooq; Steven A Narod; Asim Amin; Ute Hamann
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
International journal of cancer. Journal international du cancer 2006;119(12):2832-9.
2006: Harvey A Risch; John R McLaughlin; David E C Cole; Barry Rosen; Linda Bradley; Isabel Fan; James Tang; Song Li; Shiyu Zhang; Patricia A Shaw; Steven A Narod
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Journal of the National Cancer Institute 2006;98(23):1694-706.
2006: Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Tadeusz Debniak; Kelly Metcalfe; Steven A Narod; Jan Lubiński
Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Breast cancer research and treatment 2006;100(3):239-45.
2006: Cezary Cybulski; D Wokołorczyk; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Bohdan Górski; Tadeusz Debniak; B Masojć; Anna Jakubowska; Bartlomiej Gliniewicz; Andrzej Sikorski; M Stawicka; D Godlewski; Z Kwias; A Antczak; K Krajka; W Lauer; M Sosnowski; P Sikorska-Radek; Krzysztof Bar; Robert Klijer; R Zdrojowy; B Małkiewicz; A Borkowski; Tomasz Borkowski; Marek Szwiec; Steven A Narod; J Lubiński
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
Journal of medical genetics 2006;43(11):863-6.
2006: Robert K Nam; William W Zhang; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Joan Sweet; Ants Toi; Seamus Teahan; Vasundara Venkateswaran; Linda Sugar; Andrew Loblaw; Katherine A Siminovitch; Steven A Narod
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6452-8.
2006: Steven A Narod
Modifiers of risk of hereditary breast cancer.
Oncogene 2006;25(43):5832-6.
2006: Mario E Beiner; Barry Rosen; Anthony Fyles; Ian Harley; Tuya Pal; Katherine A Siminovitch; Shiyu Zhang; Ping Sun; Steven A Narod
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(9):1636-40.
2006: Jolanta Szymanska-Pasternak; Anna Szymanska; Krzysztof Medrek; Evgeny N Imyanitov; Cezary Cybulski; Bohdan Gorski; P Magnowski; I Dziuba; K Gugala; Boguslaw Debniak; S Gozdz; Anna Sokolenko; N Y Krylova; O S Lobeiko; Steven A Narod; Jan Lubinski
CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Gynecologic oncology 2006;102(3):429-31.
2006: Mohammad Reza Akbari; Reza Malekzadeh; dariush nasrollahzadeh; Dayan Amanian; Ping Sun; Farhad Islami; Masoud Sotoudeh; Shahriar Semnani; Paolo Boffeta; Sanford M Dawsey; Parviz Ghadirian; Steven A Narod
Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran.
International journal of cancer. Journal international du cancer 2006;119(5):1047-51.
2006: Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Tadeusz Debniak; Dominika Wokolorczyk; Anna Jakubowska; Elzbieta Kowalska; Oleg Oszurek; Steven A Narod; Jan Lubinski
CHEK2-positive breast cancers in young Polish women.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4832-5.
2006: André Nkondjock; André Robidoux; Yosabeth Paredes; Steven A Narod; Parviz Ghadirian
Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
Breast cancer research and treatment 2006;98(3):285-94.
2006: Amy Finch; Mario E Beiner; Jan Lubinski; Henry T Lynch; Pal Moller; Barry Rosen; Joan Murphy; Parviz Ghadirian; Eitan Friedman; William D Foulkes; Charmaine Kim-Sing; Teresa Wagner; Nadine Tung; Fergus J. Couch; Dominique Stoppa-Lyonnet; Peter Ainsworth; Mary Daly; Barbara Pasini; Ruth Gershoni-Baruch; Charis Eng; Olufunmilayo I Olopade; Jane McLennan; Beth Y Karlan; Jeffrey N Weitzel; Ping Sun; Steven A Narod
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
JAMA : the journal of the American Medical Association 2006;296(2):185-92.
2006: Dalal Aziz; Ellen Rawlinson; Steven A Narod; Ping Sun; H Lavina A Lickley; David R McCready; Claire Holloway
The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
The breast journal 2006;12(4):331-7.
2006: Tadeusz Debniak; Rodney J Scott; Tomasz Huzarski; Tomasz Byrski; B Masojć; Thierry van de Wetering; Pablo Serrano-Fernandez; Bohdan Górski; Cezary Cybulski; Jacek Gronwald; Boguslaw Debniak; Romuald Maleszka; J Kładny; A Bieniek; L Nagay; Olga Haus; E Grzybowska; Piotr Wandzel; S Niepsuj; Steven A Narod; Jan Lubinski
XPD common variants and their association with melanoma and breast cancer risk.
Breast cancer research and treatment 2006;98(2):209-15.
2006: Tadeusz Debniak; Rodney J Scott; Tomasz Huzarski; Tomasz Byrski; Andrzej Rozmiarek; Boguslaw Debniak; Bohdan Górski; Cezary Cybulski; Krzysztof Medrek; Marek Mierzejewski; Bartlomiej Masojc; Joanna Matyjasik; Elzbieta Złowocka; Urszula Teodorczyk; Marcin Lener; Ewa Klujszo-Grabowska; Katarzyna Nej-Wołosiak; Ewa Jaworowska; Dorota Oszutowska; Anna Szymańska; Jolanta Szymańska; Jennifer Lucero Castaneda; Thierry van de Wetering; Janina Suchy; Grzegorz Kurzawski; Oleg Oszurek; Steven A Narod; Jan Lubinski
CDKN2A common variant and multi-organ cancer risk--a population-based study.
International journal of cancer. Journal international du cancer 2006;118(12):3180-2.
2006: Lori J Pierce; Al Levin; Timothy R Rebbeck; Merav A Ben-David; Eitan Friedman; Lawrence J Solin; Eleanor E R Harris; David K Gaffney; Bruce G Haffty; Laura A Dawson; Steven A Narod; Ivo A Olivotto; Andrea Eisen; Timothy J Whelan; Olufunmilayo I Olopade; Claudine Isaacs; Sofia D Merajver; Julia S Wong; Judy E Garber; Barbara L Weber
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2437-43.
2006: Steven A Narod; Jan Lubinski; Parviz Ghadirian; Henry T Lynch; Pal Moller; William D Foulkes; Barry Rosen; Charmaine Kim-Sing; Claudine Isaacs; Susan M Domchek; Susan Domcheck; Ping Sun
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
The lancet oncology 2006;7(5):402-6.
2006: Jacek Gronwald; Nadine Tung; William D Foulkes; Kenneth Offit; Ruth Gershoni; Mary Daly; Charmaine Kim-Sing; Håkan Olsson; Peter Ainsworth; Andrea Eisen; Howard M Saal; Eitan Friedman; Olufunmilayo I Olopade; Michael Osborne; Jeffrey N Weitzel; Henry T Lynch; Parviz Ghadirian; Jan Lubinski; Ping Sun; Steven A Narod
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
International journal of cancer. Journal international du cancer 2006;118(9):2281-4.
2006: Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Steven A Narod; Jan Lubinski
Male to female ratio among offspring of BRCA1 mutation carriers.
Breast cancer research and treatment 2006;97(1):113-4.
2006: Jacek Gronwald; Tomasz Huzarski; B Byrski; Krzysztof Medrek; Janusz Menkiszak; Alvaro Monteiro; Ping Sun; Jan Lubinski; Steven A Narod
Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
Journal of medical genetics 2006;43(5):424-8.
2006: Robert K Nam; Ants Toi; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Andrew Loblaw; Gregory R Pond; Marjan Emami; Linda Sugar; Joan Sweet; Steven A Narod
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
The Canadian journal of urology 2006;13 Suppl 2():2-10.
2006: Robert K Nam; Jonathan R Reeves; Ants Toi; Hélène Dulude; John Trachtenberg; Marjan Emami; Luc Daigneault; Chandra Panchal; Linda Sugar; Michael A S Jewett; Steven A Narod
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
The Journal of urology 2006;175(4):1291-7.
2006: Joanne Kotsopoulos; Alexander Liede; Maria Lourdes Leon De Matsuda; Ping Sun; Steven A Narod
Method of cooking and risk of breast cancer in the Philippines.
Cancer causes & control : CCC 2006;17(3):341-8.
2006: Henry T Lynch; Carrie Snyder; Jane F Lynch; Peggy Karatoprakli; Abdon Trowonou; Kelly A Metcalfe; Steven A Narod; Gordon Gong
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.
Cancer genetics and cytogenetics 2006;165(2):91-7.
2006: Susan Colilla; Philip W Kantoff; Susan L Neuhausen; Andrew K Godwin; Mary B Daly; Steven A Narod; Judy E Garber; Henry T Lynch; Myles Brown; Barbara L Weber; Timothy R Rebbeck
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
Carcinogenesis 2006;27(3):599-605.
2006: Robert K Nam; Ants Toi; John Trachtenberg; Laurence H Klotz; Michael A S Jewett; Marjan Emami; Linda Sugar; Joan Sweet; Gregory R Pond; Steven A Narod
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
The Journal of urology 2006;175(2):489-94.
2006: H Leon Bradlow; Helena Jernström; Daniel W Sepkovic; Thomas L Klug; Steven A Narod
Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites.
Molecular genetics and metabolism 2006;87(2):135-46.
2006: Steven A Narod
Regarding the use of tamoxifen post-oophorectomy to prevent hereditary breast cancer.
Hereditary cancer in clinical practice 2006;4(4):167-8.
2006: Tomasz Huzarski; Elzbieta Kowalska; Steven A Narod; Stanislaw Zajaczek; Tomasz Byrski; Cezary Cybulski; Bohdan Górski; Jacek Gronwald; Jowita Huzarska; Jan Lubinski
A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet.
Hereditary cancer in clinical practice 2006;4(1):58.
2006: Tadeusz Debniak; Bohdan Górski; Ewa Grabowska-Kłujszo; Jacek Gronwald; Tomasz Huzarski; Anna Jakubowska; Grzegorz Kurzawski; Marcin Lener; Bartlomiej Masojc; Joanna Matyjasik; Krzysztof Medrek; Marek Mierzejewski; Steven A Narod; Katarzyna Nej-Wołosiak; Oleg Oszurek; Rodney Scott; Janina Suchy; Anna Szymańska; Jolanta Szymańska-Pasternak; Urszula Teodorczyk; Aleksandra Tołoczko-Grabarek; Thierry van de Wetering; Elzbieta Złowocka; Tomasz Byrski; Jennifer Lucero Castaneda; Cezary Cybulski; Jan Lubinski
Low-risk Genes and Multi-organ Cancer Risk in the Polish Population.
Hereditary cancer in clinical practice 2006;4(1):52-5.
2006: Shiyu Zhang; Graciela Kuperstein; Steven A Narod
Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): detecting mutations in the BRCA1 gene.
Nature protocols 2006;1(6):3101-10.
2006: Eitan Friedman; Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Susan L Neuhausen; Claudine Isaacs; Barbara Weber; William D Foulkes; Pal Moller; Barry Rosen; Charmaine Kim-Sing; Ruth Gershoni-Baruch; Peter Ainsworth; Mary Daly; Nadine Tung; Andrea Eisen; Olufunmilayo I Olopade; Beth Y Karlan; Howard M Saal; Judy E Garber; Gad Rennert; Dawna Gilchrist; Charis Eng; Kenneth Offit; Michael Osborne; Ping Sun; Steven A Narod
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
Breast cancer research : BCR 2006;8(2):R15.
2006: Graciela Kuperstein; Elaine Jack; Steven A Narod
A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.
Genetic testing 2006;10(1):1-7.
2006: Olga M Sinilnikova; Sylvie Mazoyer; Colette Bonnardel; Henry T Lynch; Steven A Narod; Gilbert M Lenoir
BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
Familial cancer 2006;5(1):15-20.
2006: Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Cezary Cybulski; Ping Sun; Anna Tulman; Steven A Narod; Jan Lubinski
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
Breast cancer research and treatment 2006;95(2):105-9.
2006: Nathan Ellis; Tomas Kirchhoff; Nandita Mitra; Tian-Zhang Ye; Shaokun Chuai; Helen Huang; Khedoudja Nafa; Larry Norton; Susan L Neuhausen; Derek Gordon; Jeffery Struewing; Steven A Narod; Kenneth Offit
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
Genetic epidemiology 2006;30(1):48-61.
2006: Joanne Kotsopoulos; Jan Lubinski; Susan L Neuhausen; Henry T Lynch; Barry Rosen; Peter Ainsworth; Pal Moller; Parviz Ghadirian; Claudine Isaacs; Beth Y Karlan; Ping Sun; Steven A Narod
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Gynecologic oncology 2006;100(1):83-8.
2006: Amy Finch; Patricia Shaw; Barry Rosen; Joan Murphy; Steven A Narod; Terence J Colgan
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Gynecologic oncology 2006;100(1):58-64.
2006: André Nkondjock; Parviz Ghadirian; Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Charmaine Kim-Sing; Douglas E Horsman; Barry Rosen; Claudine Isaacs; Barbara Weber; William D Foulkes; Peter Ainsworth; Nadine Tung; Andrea Eisen; Eitan Friedman; Charis Eng; Ping Sun; Steven A Narod
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
International journal of cancer. Journal international du cancer 2006;118(1):103-7.
2005: Carey A Cullinane; Jan Lubinski; Susan L Neuhausen; Parviz Ghadirian; Henry T Lynch; Claudine Isaacs; Barbara Weber; Pal Moller; Kenneth Offit; Charmaine Kim-Sing; Eitan Friedman; Susan Randall; Barbara Pasini; Peter Ainsworth; Ruth Gershoni-Baruch; William D Foulkes; Jan Klijn; Nadine Tung; Gad Rennert; Olufunmilayo I Olopade; Fergus J. Couch; Teresa Wagner; Håkan Olsson; Ping Sun; Jeffrey N Weitzel; Steven A Narod
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
International journal of cancer. Journal international du cancer 2005;117(6):988-91.
2005: Robert K Nam; William W Zhang; Michael A S Jewett; John Trachtenberg; Laurence H Klotz; Marjan Emami; Linda Sugar; Joan Sweet; Ants Toi; Steven A Narod
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8391-7.
2005: Angelika Burger; Yuguang Gao; Yutaka Amemiya; Harriette J Kahn; Richard Kitching; Yili Yang; Ping Sun; Steven A Narod; Wedad M Hanna; Arun Seth
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
Cancer research 2005;65(22):10401-12.
2005: Timothy R Rebbeck; Tara Friebel; Theresa Wagner; Henry T Lynch; Judy E Garber; Mary B Daly; Claudine Isaacs; Olufunmilayo I Olopade; Susan L Neuhausen; Laura van 't Veer; Rosalind Eeles; D Gareth Evans; Gail Tomlinson; Ellen Matloff; Steven A Narod; Andrea Eisen; Susan M Domchek; Katrina A Armstrong; Barbara L Weber
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7804-10.
2005: Andrea Eisen; Jan Lubinski; Jan Klijn; Pal Moller; Henry T Lynch; Kenneth Offit; Barbara Weber; Tim Rebbeck; Susan L Neuhausen; Parviz Ghadirian; William D Foulkes; Ruth Gershoni-Baruch; Eitan Friedman; Gadi Rennert; Teresa Wagner; Claudine Isaacs; Charmaine Kim-Sing; Peter Ainsworth; Ping Sun; Steven A Narod
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7491-6.
2005: Tadeusz Debniak; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Cezary Cybulski; Andrzej mackiewicz; S Gozdecka-Grodecka; Jacek Gronwald; Elzbieta Kowalska; Olga Haus; E Grzybowska; M Stawicka; M Swiec; K Urbański; S Niepsuj; B Waśko; S Góźdź; Piotr Wandzel; Cezary Szczylik; D Surdyka; Andrzej Rozmiarek; O Zambrano; M Posmyk; Steven A Narod; Jan Lubinski
A common variant of CDKN2A (p16) predisposes to breast cancer.
Journal of medical genetics 2005;42(10):763-5.
2005: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Susan L Neuhausen; Parviz Ghadirian; Claudine Isaacs; Barbara Weber; Charmaine Kim-Sing; William D Foulkes; Ruth Gershoni-Baruch; Peter Ainsworth; Eitan Friedman; Mary Daly; Judy E Garber; Beth Y Karlan; Olufunmilayo I Olopade; Nadine Tung; Howard M Saal; Andrea Eisen; Michael Osborne; Håkan Olsson; Dawna Gilchrist; Ping Sun; Steven A Narod
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer causes & control : CCC 2005;16(6):667-74.
2005: Steven A Narod
Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2.
Women's health (London, England) 2005;1(1):27-34.
2005: Bohdan Górski; Cezary Cybulski; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Anna Jakubowska; M Stawicka; S Gozdecka-Grodecka; Marek Szwiec; K Urbański; J Mituś; E Marczyk; J Dziuba; Piotr Wandzel; D Surdyka; Olga Haus; H Janiszewska; Tadeusz Debniak; A Tołoczko-Grabarek; Krzysztof Medrek; B Masojć; Marek Mierzejewski; Elzbieta Kowalska; Steven A Narod; J Lubiński
Breast cancer predisposing alleles in Poland.
Breast cancer research and treatment 2005;92(1):19-24.
2005: Jeffrey N Weitzel; Mark Robson; Barbara Pasini; Siranoush Manoukian; Dominique Stoppa-Lyonnet; Henry T Lynch; Jane McLennan; William D Foulkes; Teresa Wagner; Nadine Tung; Parviz Ghadirian; Olufunmilayo I Olopade; Claudine Isaacs; Charmaine Kim-Sing; Pal Møller; Susan L Neuhausen; Kelly A Metcalfe; Ping Sun; Steven A Narod
A comparison of bilateral breast cancers in BRCA carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1534-8.
2005: Kelly A Metcalfe; John L Semple; Steven A Narod
Time to reconsider subcutaneous mastectomy for breast-cancer prevention?
The lancet oncology 2005;6(6):431-4.
2005: Elzbieta Kowalska; Steven A Narod; Tomasz Huzarski; Stanislaw Zajaczek; Jowita Huzarska; Bohdan Gorski; Jan Lubinski
Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1302-6.
2005: Robert K Nam; John Trachtenberg; Michael A S Jewett; Ants Toi; Andrew Evans; Marjan Emami; Steven A Narod; Michael Pollak
Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1270-3.
2005: Murray Joseph Casey; Carrie Synder; Chhanda Bewtra; Steven A Narod; Patrice Watson; Henry T Lynch
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Gynecologic oncology 2005;97(2):457-67.
2005: Henry T Lynch; Carolyn A Deters; Carrie L Snyder; Jane F Lynch; Pierre Villeneuve; Julie Silberstein; Holly Martin; Steven A Narod; Randall E Brand
BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
Cancer genetics and cytogenetics 2005;158(2):119-25.
2005: Steven A Narod; Kenneth Offit
Prevention and management of hereditary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1656-63.
2005: Joanne Kotsopoulos; Steven A Narod
Towards a dietary prevention of hereditary breast cancer.
Cancer causes & control : CCC 2005;16(2):125-38.
2005: Tomasz Huzarski; Cezary Cybulski; Wenancjusz Domagała; Jacek Gronwald; Tomasz Byrski; Marek Szwiec; Stanisław Woyke; Steven A Narod; Jan Lubiński
Pathology of breast cancer in women with constitutional CHEK2 mutations.
Breast cancer research and treatment 2005;90(2):187-9.
2005: Steven A Narod
BRCA1 and BRCA2 in 2005.
Discovery medicine 2005;5(25):50-4.
2005: Catherine M Phelan; Virna Dapic; B Tice; Reyna Favis; Elaine Kwan; Francis Barany; Siranoush Manoukian; Paolo Radice; Rob B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; Trinidad Caldes; Miguel de la Hoya; S Lindquist; Sean V Tavtigian; David E Goldgar; A Borg; Steven A Narod; Alvaro Monteiro
Classification of BRCA1 missense variants of unknown clinical significance.
Journal of medical genetics 2005;42(2):138-46.
2005: Jan Lubiński; Tomasz Huzarski; Grzegorz Kurzawski; Janina Suchy; Bartłomiej Masojć; Marek Mierzejewski; Marcin Lener; Wenancjusz Domagała; Maria Chosia; Urszula Teodorczyk; Krzysztof Medrek; Tadeusz Debniak; Elzbieta Złowocka; Jacek Gronwald; Tomasz Byrski; Ewa Grabowska; Katarzyna Nej; Anna Szymańska; Jolanta Szymańska; Joanna Matyjasik; Cezary Cybulski; Anna Jakubowska; Bohdan Górski; Steven A Narod
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs.
Hereditary cancer in clinical practice 2005;3(2):59-63.
2005: Kelly A Metcalfe; William D Foulkes; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo A Olivotto; Ellen Warner; Olufunmilayo Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; Steven A Narod
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Hereditary cancer in clinical practice 2005;3(2):53-7.
2005: Bohdan Górski; Steven A Narod; Jan Lubinski
A common missense variant in BRCA2 predisposes to early onset breast cancer.
Breast cancer research : BCR 2005;7(6):R1023-7.
2005: Joanne Kotsopoulos; Olufunmilayo I Olopado; Parviz Ghadirian; Jan Lubinski; Henry T Lynch; Claudine Isaacs; Barbara Weber; Charmaine Kim-Sing; Peter Ainsworth; William D Foulkes; Andrea Eisen; Ping Sun; Steven A Narod
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast cancer research : BCR 2005;7(5):R833-43.
2005: Kelly A Metcalfe; Carrie Snyder; Jennifer Seidel; Danielle Hanna; Henry T Lynch; Steven A Narod
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.
Familial cancer 2005;4(2):97-103.
2005: Lluis Quintana-Murci; Inbar Gal; Tangiz Bakhan; Hélène Quach; S Hamid Sayar; Ronit Shiri-Sverdlov; Ruth Gershoni Baruch; Ken McElreavey; Efrat Dagan; Steven A Narod; Eitan Friedman
The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
Familial cancer 2005;4(2):85-8.
2005: Tomasz Huzarski; Marcin Lener; Wenancjusz Domagała; Jacek Gronwald; Tomasz Byrski; Grzegorz Kurzawski; Janina Suchy; Maria Chosia; Janusz Woyton; Michał Ucinski; Steven A Narod; Jan Lubiński
The 3020insC allele of NOD2 predisposes to early-onset breast cancer.
Breast cancer research and treatment 2005;89(1):91-3.
2005: Kelly A Metcalfe; Mary Jane Esplen; Vivek Goel; Steven A Narod
Predictors of quality of life in women with a bilateral prophylactic mastectomy.
The breast journal 2005;11(1):65-9.
2005: Kelly A Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo A Olivotto; William D Foulkes; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; Steven A Narod
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Gynecologic oncology 2005;96(1):222-6.
2004: Robert K Nam; Ants Toi; John Trachtenberg; Michael A S Jewett; Laurence Klotz; Neil Fleshner; P Scott Bagnell; Joan Sweet; Linda Sugar; Steven A Narod
Variation in patterns of practice in diagnosing screen-detected prostate cancer.
BJU international 2004;94(9):1239-44.
2004: Bohdan Gorski; Janusz Menkiszak; Jacek Gronwald; Jan Lubinski; Steven A Narod
A protein truncating BRCA1 allele with a low penetrance of breast cancer.
Journal of medical genetics 2004;41(12):e130.
2004: Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; B Masojć; Marek Mierzejewski; Tadeusz Debniak; Urszula Teodorczyk; Tomasz Byrski; Jacek Gronwald; Joanna Matyjasik; Elzbieta Zlowocka; M Lenner; Ewa Grabowska; Katarzyna Nej; Jennifer Lucero Castaneda; Krzysztof Medrek; A Szymańska; J Szymańska; Grzegorz Kurzawski; Janina Suchy; Oleg Oszurek; A Witek; Steven A Narod; J Lubiński
CHEK2 is a multiorgan cancer susceptibility gene.
American journal of human genetics 2004;75(6):1131-5.
2004: Mary Jane Esplen; Jon Hunter; Molyn Leszcz; Ellen Warner; Steven A Narod; Kelly A Metcalfe; Gord Glendon; Kate Butler; Alexander Liede; Mary Anne Young; Stephanie Kieffer; Lisa DiProspero; Ellen Irwin; Jiahui Wong
A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations.
Cancer 2004;101(10):2327-40.
2004: Kathleen K Oros; Parviz Ghadirian; Celia M T Greenwood; Chantal Perret; Zhen Shen; Yosabeth Paredes; Suzanna L Arcand; Anne-Marie Mes-Masson; Steven A Narod; William D Foulkes; Diane Provencher; Patricia N Tonin
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.
International journal of cancer. Journal international du cancer 2004;112(3):411-9.
2004: Karen P L Yap; David R McCready; Anthony Fyles; Lee Manchul; Maureen Trudeau; Steven A Narod
Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery.
The breast journal 2004;10(6):481-6.
2004: Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
JAMA : the journal of the American Medical Association 2004;292(11):1317-25.
2004: Steven A Narod; William D Foulkes
BRCA1 and BRCA2: 1994 and beyond.
Nature reviews. Cancer 2004;4(9):665-76.
2004: Chanita Hughes Halbert; Marc D Schwartz; Lari Wenzel; Steven A Narod; Beth N Peshkin; David Cella; Caryn Lerman
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
Journal of behavioral medicine 2004;27(4):373-92.
2004: Kelly A Metcalfe; John L Semple; Steven A Narod
Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.
Plastic and reconstructive surgery 2004;114(2):360-6.
2004: Helena Jernström; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Susan L Neuhausen; Claudine Isaacs; Barbara L Weber; Douglas E Horsman; Barry Rosen; William D Foulkes; Eitan Friedman; Ruth Gershoni-Baruch; Peter Ainsworth; Mary Daly; Judy E Garber; Håkan Olsson; Ping Sun; Steven A Narod
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2004;96(14):1094-8.
2004: Parviz Ghadirian; Jan Lubinski; Henry T Lynch; Susan L Neuhausen; Barbara Weber; Claudine Isaacs; Ruth Gershoni Baruch; Susan Randall; Peter Ainsworth; Eitan Friedman; Eitan Freidman; Douglas E Horsman; Patricia N Tonin; William D Foulkes; Nadine Tung; Ping Sun; Steven A Narod
Smoking and the risk of breast cancer among carriers of BRCA mutations.
International journal of cancer. Journal international du cancer 2004;110(3):413-6.
2004: Kelly A Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2328-35.
2004: Chanita Hughes Halbert; Lari Wenzel; Caryn Lerman; Beth N Peshkin; Steven A Narod; Alfred Marcus; Camille Corio; Tiffani A Demarco; Scarlett Bellamy
Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(5):875-81.
2004: David R McCready; Kristan J Aronson; William Chu; Wenli Fan; Danny Vesprini; Steven A Narod
Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada.
Cancer causes & control : CCC 2004;15(4):399-418.
2004: Cezary Cybulski; Tomasz Huzarski; Bohdan Górski; Bartłomiej Masojć; Marek Mierzejewski; Tadeusz Debniak; Bartlomiej Gliniewicz; Joanna Matyjasik; Elzbieta Złowocka; Grzegorz Kurzawski; Andrzej Sikorski; Michał Posmyk; Marek Szwiec; Ryszard Czajka; Steven A Narod; Jan Lubiński
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cancer research 2004;64(8):2677-9.
2004: Joe H Lai; Danny Vesprini; William Zhang; Martin J Yaffe; Michael Pollak; Steven A Narod
A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(4):573-82.
2004: William D Foulkes; Kelly A Metcalfe; Ping Sun; Wedad M Hanna; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Olufunmilayo I Olopade; Barbara L Weber; Jane McLennan; Ivo A Olivotto; Louis R Bégin; Steven A Narod
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):2029-34.
2004: Jordana Segal; Mary Jane Esplen; Brenda B Toner; Sylvia Baedorf; Steven A Narod; Kate Butler
An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.
American journal of medical genetics. Part A 2004;125A(3):267-72.
2004: Timothy R Rebbeck; Tara Friebel; Henry T Lynch; Susan L Neuhausen; Laura van 't Veer; Judy E Garber; Gareth R Evans; Steven A Narod; Claudine Isaacs; Ellen Matloff; Mary B Daly; Olufunmilayo I Olopade; Barbara L Weber
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1055-62.
2004: Cezary Cybulski; Bohdan Górski; Tadeusz Debniak; Bartlomiej Gliniewicz; Marek Mierzejewski; B Masojć; Anna Jakubowska; Joanna Matyjasik; E Złowocka; Andrzej Sikorski; Steven A Narod; J Lubiński
NBS1 is a prostate cancer susceptibility gene.
Cancer research 2004;64(4):1215-9.
2004: Alexander Liede; Beth Y Karlan; Steven A Narod
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):735-42.
2004: Isabelle Thiffault; Nancy Hamel; T Pal; Susan McVety; Victoria A Marcus; David Farber; Shannon Cowie; Jean Deschênes; Wendy S Meschino; Fabrice Odefrey; David E Goldgar; T Graham; Steven A Narod; A Kevin Watters; Elizabeth MacNamara; Desirée Du Sart; George Chong; William D Foulkes
Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.
British journal of cancer 2004;90(2):483-91.
2004: Jan Lubinski; Catherine M Phelan; Parviz Ghadirian; Henry T Lynch; Judy E Garber; Barbara Weber; Nadine Tung; Douglas E Horsman; Claudine Isaacs; Alvaro Monteiro; Ping Sun; Steven A Narod
Cancer variation associated with the position of the mutation in the BRCA2 gene.
Familial cancer 2004;3(1):1-10.
2004: Janusz Menkiszak; Jacek Gronwald; Bohdan Górski; Tomasz Byrski; Tomasz Huzarski; Anna Jakubowska; M Foszczyńska-Kłoda; Marek Brzosko; J Fliciński; Izabella Rzepka-Górska; Steven A Narod; J Lubiński
Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2.
European journal of gynaecological oncology 2004;25(1):99-100.
2004: Janusz Menkiszak; Izabella Rzepka-Górska; Bohdan Górski; Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Anna Jakubowska; K A Metcalfe; Steven A Narod; J Lubiński
Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland.
European journal of gynaecological oncology 2004;25(1):93-5.
2004: Kelly A Metcalfe; Mary Jane Esplen; Vivek Goel; Steven A Narod
Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Psycho-oncology 2004;13(1):14-25.
2003: Robert K Nam; William W Zhang; John Trachtenberg; Michael A S Jewett; Marjan Emami; Danny Vesprini; William Chu; Minnie Ho; Joan Sweet; Andrew Evans; Ants Toi; Michael Pollak; Steven A Narod
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1429-37.
2003: Anna Jakubowska; Rodney Scott; Janusz Menkiszak; Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Bohdan Górski; Cezary Cybulski; Tadeusz Debniak; Elzbieta Kowalska; Teresa Starzyńska; Małgorzata Ławniczak; Steven A Narod; Jan Lubinski
A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer.
European journal of human genetics : EJHG 2003;11(12):955-8.
2003: Steve Edwards; Julia Meitz; Ros Eles; Chris Evans; Douglas Easton; John Hopper; Graham Giles; William D Foulkes; Steven A Narod; Jacques Simard; Michael D Badzioch; Lovise Mahle
Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
The Prostate 2003;57(4):270-9.
2003: William D Foulkes; Steven A Narod; Kenneth Swenerton; Karen Panabaker; Lucy Gilbert
Re: Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Journal of the National Cancer Institute 2003;95(21):1640.
2003: Steven A Narod; Jan Lubinski
Re: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
Journal of the National Cancer Institute 2003;95(20):1552.
2003: William D Foulkes; Kelly A Metcalfe; Wedad M Hanna; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Olufunmilayo I Olopade; Barbara Weber; Jane McLennan; Ivo A Olivotto; Ping Sun; Pierre O Chappuis; Louis R Bégin; Jean-Sebastien Brunet; Steven A Narod
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma.
Cancer 2003;98(8):1569-77.
2003: Alexander Liede; William Zhang; Maria Lourdes De Leon Matsuda; Alex Tan; Steven A Narod
Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(9):848-52.
2003: Jacek Gronwald; Bohdan Gorski; Tomasz Byrski; Tomasz Huzarski; Anna Jakubowska; Janusz Menkiszak; Steven A Narod; Jan Lubinski
Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland.
Journal of medical genetics 2003;40(9):719-20.
2003: Patrice Watson; Steven A Narod; Riccardo Fodde; Anja Wagner; Jane F Lynch; Susan Tinley; Carrie L Snyder; S A Coronel; B Riley; Yulia Kinarsky; Henry T Lynch
Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.
Journal of medical genetics 2003;40(8):591-6.
2003: Wai Lun Alan Fung; Harvey A Risch; John McLaughlin; Barry Rosen; David Cole; Danny Vesprini; Steven A Narod
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(7):678-80.
2003: Robert K Nam; William W Zhang; John Trachtenberg; Eleftherios Diamandis; Ants Toi; Marjan Emami; Minnie Ho; Joan Sweet; Andrew Evans; Michael A S Jewett; Steven A Narod
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2312-9.
2003: Francesmary Modugno; Roxana Moslehi; Roberta B Ness; Deborah Brooks Nelson; Steven H Belle; Jeffrey A Kant; James E Wheeler; Aimee Wonderlick; David Fishman; Beth Y Karlan; Harvey A Risch; Daniel W Cramer; Marie-Pierre Dube; Steven A Narod
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).
Cancer causes & control : CCC 2003;14(5):439-46.
2003: Harvey A Risch; Steven A Narod
Re: Cancer risks in BRCA1 carriers: time for the next generation of studies.
Journal of the National Cancer Institute 2003;95(10):758.
2003: Helena Jernström; Thomas L Klug; Daniel W Sepkovic; H Leon Bradlow; Steven A Narod
Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
Carcinogenesis 2003;24(5):991-1005.
2003: Anna Jakubowska; Steven A Narod; David E Goldgar; Marek Mierzejewski; Bartłomiej Masojć; Katarzyna Nej; Jowita Huzarska; Tomasz Byrski; Bohdan Górski; Jan Lubiński
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(5):457-9.
2003: Ilana Cass; Rae Lynn Baldwin; Taz Varkey; Roxana Moslehi; Steven A Narod; Beth Y Karlan
Improved survival in women with BRCA-associated ovarian carcinoma.
Cancer 2003;97(9):2187-95.
2003: Sean P Cleary; William Zhang; Nando Di Nicola; Melyssa Aronson; Jennifer Aube; Amanda Steinman; Riad Haddad; Mark Redston; Steven Gallinger; Steven A Narod; Robert Gryfe
Heterozygosity for the BLM(Ash) mutation and cancer risk.
Cancer research 2003;63(8):1769-71.
2003: Alvaro Monteiro; S Zhang; Catherine M Phelan; Steven A Narod
Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families.
Journal of medical genetics 2003;40(4):e51.
2003: Karen P L Yap; David R McCready; Steven A Narod; Lee Manchul; Maureen Trudeau; Anthony Fyles
Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma.
Cancer 2003;97(6):1369-75.
2003: Roxana Moslehi; M Hassan Kariminejad; Vahraz Ghafari; Steven A Narod
Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome.
American journal of medical genetics. Part A 2003;117A(3):304-5.
2003: Steven A Narod; Håkan Olsson
Risk of ovarian cancer in breast-cancer patients with a family history of either.
Lancet 2003;361(9352):179; author reply 179-80.
2003: Harvey A Risch; Steven A Narod
Re: On the use of familial aggregation in population-based case probands for calculating penetrance.
Journal of the National Cancer Institute 2003;95(1):73-4; author reply 77-8.
2002: Kelly A Metcalfe; Alexander Liede; M Trinkaus; Danielle Hanna; Steven A Narod
Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2.
Clinical genetics 2002;62(6):464-9.
2002: Jaya M Satagopan; Jeff Boyd; Noah D Kauff; Mark Robson; Lauren Scheuer; Steven A Narod; Kenneth Offit
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3776-81.
2002: Alexander Liede; Steven A Narod
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.
Human mutation 2002;20(6):413-24.
2002: Catherine M Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer Aubé; Danielle Hanna; Steven A Narod
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Human mutation 2002;20(5):352-7.
2002: Kelly A Metcalfe; Steven A Narod
Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.
Journal of the National Cancer Institute 2002;94(20):1564-9.
2002: Patricia A Shaw; John R McLaughlin; Ronald P Zweemer; Steven A Narod; Harvey A Risch; René H M Verheijen; A Ryan; Fred H Menko; Peter Kenemans; Ian J Jacobs
Histopathologic features of genetically determined ovarian cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2002;21(4):407-11.
2002: Alexander Liede; Imtiaz A Malik; Zeba Aziz; Patricia de los Rios Pd; Elaine Kwan; Steven A Narod
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.
American journal of human genetics 2002;71(3):595-606.
2002: Kelly A Metcalfe; Vivek Goel; Lavina Lickley; John Semple; Steven A Narod
Prophylactic bilateral mastectomy: patterns of practice.
Cancer 2002;95(2):236-42.
2002: Terence J Colgan; Scott L Boerner; Joan Murphy; David E C Cole; Steven A Narod; Barry Rosen
Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy.
Gynecologic oncology 2002;85(3):397-403.
2002: Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
The New England journal of medicine 2002;346(21):1616-22.
2002: Steven A Narod
What options for treatment of hereditary breast cancer?
Lancet 2002;359(9316):1451-2.
2002: Alexander Liede; Elaine Jack; Robert A Hegele; Steven A Narod
A BRCA1 mutation in Native North American families.
Human mutation 2002;19(4):460.
2002: Maria Lourdes De Leon Matsuda; Alexander Liede; Elaine Kwan; Cynthia A Mapua; Eva Maria C Cutiongco; Alex Tan; Ake Borg; Steven A Narod
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines.
International journal of cancer. Journal international du cancer 2002;98(4):596-603.
2002: Alexander Liede; Beth Y Karlan; Rae Lynn Baldwin; Lawrence D Platt; Graciela Kuperstein; Steven A Narod
Cancer incidence in a population of Jewish women at risk of ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1570-7.
2002: Naomi E Allen; Gwyneth K Davey; Timothy J Key; Shiyu Zhang; Steven A Narod
Serum insulin-like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(3):319-20.
2002: Parviz Ghadirian; Geoffrey Liu; Steven Gallinger; Beverly Schmocker; Ann-Josée Paradis; Geeta Lal; Jean-Sebastien Brunet; William D Foulkes; Steven A Narod
Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas.
International journal of cancer. Journal international du cancer 2002;97(6):807-10.
2002: Steven A Narod
Modifiers of risk of hereditary breast and ovarian cancer.
Nature reviews. Cancer 2002;2(2):113-23.
2002: Raluca Nedelcu; Alexander Liede; Jennifer Aubé; Amy Finch; Elaine Kwan; Elaine Jack; Steven A Narod; Susan Randall; Lara Hugel; Katherine Clark
BRCA mutations in Italian breast/ovarian cancer families.
European journal of human genetics : EJHG 2002;10(2):150-2.
2002: Steven A Narod; Jeff Boyd
Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer.
Current opinion in obstetrics & gynecology 2002;14(1):19-26.
2002: Chanita Hughes; Caryn Lerman; Marc Schwartz; Beth N Peshkin; Lari Wenzel; Steven A Narod; Camille Corio; Kenneth P Tercyak; Danielle Hanna; Claudine Isaacs; David Main
All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
American journal of medical genetics 2002;107(2):143-50.
2002: Laurie Elit; G Baigal; Elaine Jack; A Munkhtaivan; Steven A Narod
Risk factors for ovarian cancer and early-onset breast cancer in Mongolia.
European journal of gynaecological oncology 2002;23(5):397-400.
2002: Laurie Elit; T Pal; R Goshen; H Jernström; Ida Ackerman; Anthony Fyles; Mark Carey; M Mitchell; J Aube; Steven A Narod
Familial and hormonal risk factors for papillary serous uterine cancer.
European journal of gynaecological oncology 2002;23(3):187-90.
2001: Steven A Narod
Hormonal prevention of hereditary breast cancer.
Annals of the New York Academy of Sciences 2001;952():36-43.
2001: J Lai; Danny Vesprini; William Chu; Helena Jernström; Steven A Narod
CYP gene polymorphisms and early menarche.
Molecular genetics and metabolism 2001;74(4):449-57.
2001: Ingo B Runnebaum; Shan Wang-Gohrke; Danny Vesprini; Rolf Kreienberg; Henry T Lynch; Roxana Moslehi; Parviz Ghadirian; Barbara Weber; Andrew K Godwin; Harvey A Risch; Judy E Garber; C Lerman; Olufunmilayo I Olopade; William D Foulkes; Beth Y Karlan; Ellen Warner; Barry Rosen; Timothy R Rebbeck; P Tonin; M P Dubé; Dirk G Kieback; Steven A Narod
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.
Pharmacogenetics 2001;11(7):635-8.
2001: Steven Bevan; T Pal; C R Greenberg; Helen Green; Julie Wixey; Graham R Bignell; Steven A Narod; WD Foulkes; Michael R Stratton; richard Houlston
A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
The Journal of clinical endocrinology and metabolism 2001;86(8):3701-4.
2001: Ellen Warner; Donald B Plewes; Rene S Shumak; G C Catzavelos; LS Di Prospero; Martin J Yaffe; Vivek Goel; Elizabeth A Ramsay; Pamela L Chart; D E Cole; G A Taylor; M Cutrara; T H Samuels; J P Murphy; J M Murphy; Steven A Narod
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3524-31.
2001: Timothy R Rebbeck; Yiting Wang; Philip W Kantoff; K Krithivas; Susan L Neuhausen; Andrew K Godwin; Mary B Daly; Steven A Narod; Jean-Sebastien Brunet; Danny Vesprini; Judy E Garber; Henry T Lynch; Barbara L Weber; Myles Brown
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.
Cancer research 2001;61(14):5420-4.
2001: Steven A Narod; Ping Sun; Parviz Ghadirian; Henry T Lynch; Claudine Isaacs; Judy E Garber; Barbara Weber; Beth Y Karlan; David Fishman; Barry Rosen; Nadine Tung; Susan L Neuhausen
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
Lancet 2001;357(9267):1467-70.
2001: Laurie Elit; Elaine Jack; Elaine Kwan; G Baigal; Steven A Narod
A unique BRCA1 mutation identified in Mongolia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(3):241-3.
2001: Helena Jernström; Danny Vesprini; H Leon Bradlow; Steven A Narod
Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Journal of the National Cancer Institute 2001;93(7):554-5.
2001: Helena Jernström; Cheri Deal; F Wilkin; William Chu; Y Tao; Noreen Majeed; T Hudson; Steven A Narod; Michael Pollak
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(4):377-84.
2001: Danny Vesprini; Robert K Nam; John Trachtenberg; Michael A S Jewett; S V Tavtigian; Marjan Emami; Minnie Ho; Ants Toi; Steven A Narod
HPC2 variants and screen-detected prostate cancer.
American journal of human genetics 2001;68(4):912-7.
2001: S Aziz; Graciela Kuperstein; Barry Rosen; D Cole; R Nedelcu; J McLaughlin; Steven A Narod
A genetic epidemiological study of carcinoma of the fallopian tube.
Gynecologic oncology 2001;80(3):341-5.
2001: Harvey A Risch; John R McLaughlin; David E C Cole; Barry Rosen; L Bradley; Elaine Kwan; Elaine Jack; Danny Vesprini; Graciela Kuperstein; JL Abrahamson; I Fan; B Wong; Steven A Narod
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
American journal of human genetics 2001;68(3):700-10.
2001: P de los Rios; Elaine Jack; Graciela Kuperstein; H Lynch; J Lubinski; Steven A Narod
Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.
American journal of human genetics 2001;68(2):546.
2001: Helena Jernström; William Chu; Danny Vesprini; Y Tao; Noreen Majeed; Cheri Deal; Michael Pollak; Steven A Narod
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
Molecular genetics and metabolism 2001;72(2):144-54.
2001: Steven A Narod; T Pal; T Graham; M Mitchell; A Fyles
Tamoxifen and risk of endometrial cancer.
Lancet 2001;357(9249):65-6; author reply 67.
2001: Laurie Elit; Mary Jane Esplen; K Butler; Steven A Narod
Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.
Familial cancer 2001;1(3-4):149-56.
2001: T Pal; Nancy Hamel; Danny Vesprini; K Sanders; M Mitchell; Nada Quercia; N Ng Cheong; A Murray; William D Foulkes; Steven A Narod
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications.
Familial cancer 2001;1(1):17-24.
2001: A P Manning; D Abelovich; Parviz Ghadirian; J A Lambert; Danielle Frappier; Diane Provencher; André Robidoux; T Peretz; Steven A Narod; Anne-Marie Mes-Masson; William D Foulkes; T Wang; Kenneth Morgan; T Mary Fujiwara; Patricia N Tonin
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families.
Human heredity 2001;52(2):116-20.
2000: Pierre O Chappuis; Linda Kapusta; Louis R Bégin; Nora Wong; Jean-Sebastien Brunet; Steven A Narod; Joyce M Slingerland; William D Foulkes
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(24):4045-52.
2000: Steven A Narod; Jean-Sebastien Brunet; Parviz Ghadirian; Mark Robson; K Heimdal; Susan L Neuhausen; D Stoppa-Lyonnet; C Lerman; Barbara Pasini; P de los Rios; Barbara Weber; Henry T Lynch
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Lancet 2000;356(9245):1876-81.
2000: George S Charames; A L Millar; T Pal; Steven A Narod; Bharati Bapat
Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?
Human genetics 2000;107(6):623-9.
2000: R Goshen; W Chu; Laurie Elit; T Pal; J Hakimi; Ida Ackerman; Anthony Fyles; M Mitchell; Steven A Narod
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
Gynecologic oncology 2000;79(3):477-81.
2000: Alexander Liede; Kelly A Metcalfe; Danielle Hanna; E Hoodfar; Carrie Snyder; C Durham; Henry T Lynch; Steven A Narod
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
American journal of human genetics 2000;67(6):1494-504.
2000: Kelly A Metcalfe; Alexander Liede; E Hoodfar; A Scott; William D Foulkes; Steven A Narod
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.
Journal of medical genetics 2000;37(11):866-74.
2000: Rae Lynn Baldwin; E Nemeth; Hang Tran; H Shvartsman; Ilana Cass; Steven A Narod; Beth Y Karlan
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Cancer research 2000;60(19):5329-33.
2000: Lori J Pierce; Myla S Strawderman; Steven A Narod; I Oliviotto; Andrea Eisen; Laura Dawson; David Gaffney; Lawrence J Solin; Asa Nixon; Judy E Garber; C Berg; Claudine Isaacs; R Heimann; Olufunmilayo I Olopade; Bruce G Haffty; Barbara L Weber
Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3360-9.
2000: Caryn Lerman; Chanita Hughes; R T Croyle; David Main; C Durham; Carrie Snyder; A Bonney; Jane F Lynch; Steven A Narod; Henry T Lynch
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
Preventive medicine 2000;31(1):75-80.
2000: Bohdan Górski; Tomasz Byrski; Tomasz Huzarski; Anna Jakubowska; Janusz Menkiszak; Jacek Gronwald; A Pluzańska; M Bebenek; L Fischer-Maliszewska; E Grzybowska; Steven A Narod; J Lubiński
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
American journal of human genetics 2000;66(6):1963-8.
2000: Mary Jane Esplen; Brenda B Toner; Jon Hunter; Gord Glendon; Alexander Liede; Steven A Narod; Noreen Stuckless; Kate Butler; B Field
A supportive-expressive group intervention for women with a family history of breast cancer: results of a phase II study.
Psycho-oncology 2000;9(3):243-52.
2000: Geoffrey Liu; Parviz Ghadirian; Danny Vesprini; Nancy Hamel; Ann-Josée Paradis; Geeta Lal; Steven Gallinger; Steven A Narod; William D Foulkes
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.
British journal of cancer 2000;82(10):1646-9.
2000: Reyna Favis; JP Day; Norman P Gerry; Catherine M Phelan; Steven A Narod; Francis Barany
Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2.
Nature biotechnology 2000;18(5):561-4.
2000: Nazneen Rahman; Laura Arbour; R Houlston; Catherine Bonaïti-Pellié; fatima abidi; J Tranchemontagne; D Ford; Steven A Narod; Kathy Pritchard-Jones; WD Foulkes; C Schwartz; Michael R Stratton
Penetrance of mutations in the familial Wilms tumor gene FWT1.
Journal of the National Cancer Institute 2000;92(8):650-2.
2000: Roxana Moslehi; W Chu; Beth Y Karlan; David Fishman; Harvey A Risch; A Fields; David Smotkin; Yaacov Ben David; Joseph D Rosenblatt; D Russo; P Schwartz; Nadine Tung; Ellen Warner; Barry Rosen; J Friedman; Jean-Sebastien Brunet; Steven A Narod
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
American journal of human genetics 2000;66(4):1259-72.
2000: Harriette J Kahn; Lu-Ying Yang; John Blondal; Lavina A Lickley; Claire Holloway; Wedad M Hanna; Steven A Narod; David R McCready; Arun Seth; Alexander Marks
RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
Breast cancer research and treatment 2000;60(2):143-51.
2000: William D Foulkes; Pierre O Chappuis; Nora Wong; Jean-Sebastien Brunet; Danny Vesprini; F Rozen; Ziqiang Yuan; MN Pollak; G Kuperstein; Steven A Narod; Louis R Bégin
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):307-13.
2000: Graciela Kuperstein; William D Foulkes; Parviz Ghadirian; J Hakimi; Steven A Narod
A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes.
Clinical genetics 2000;57(3):213-20.
2000: Alexander Liede; B Cohen; D M Black; R H Davidson; A Renwick; E Hoodfar; Olufunmilayo I Olopade; M Micek; V Anderson; R De Mey; A Fordyce; Ellen Warner; JL Dann; Mary-Claire King; Barbara Weber; Steven A Narod; C M Steel
Evidence of a founder BRCA1 mutation in Scotland.
British journal of cancer 2000;82(3):705-11.
2000: Geeta Lal; Geoffrey Liu; Beverly Schmocker; P Kaurah; Hilmi Ozcelik; Steven A Narod; Mark Redston; Steven Gallinger
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Cancer research 2000;60(2):409-16.
2000: Roxana Moslehi; D Russo; Catherine M Phelan; Elaine Jack; K Antman; Steven A Narod
An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2.
Clinical genetics 2000;57(1):70-3.
1999: William D Foulkes; Jean-Sebastien Brunet; Ellen Warner; P J Goodwin; Wendy S Meschino; Steven A Narod; P E Goss; Gord Glendon
The importance of a family history of breast cancer in predicting the presence of a BRCA mutation.
American journal of human genetics 1999;65(6):1776-9.
1999: Helena Jernström; C Lerman; Parviz Ghadirian; Henry T Lynch; Barbara Weber; Judy E Garber; Mary Daly; Olufunmilayo I Olopade; William D Foulkes; Ellen Warner; Jean-Sebastien Brunet; Steven A Narod
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
Lancet 1999;354(9193):1846-50.
1999: Victoria A Marcus; Lisa Madlensky; Robert Gryfe; H Kim; K So; Anna Millar; Larissa K Temple; ET Hsieh; T Hiruki; Steven A Narod; Bharati Bapat; Steven Gallinger; Mark Redston
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
The American journal of surgical pathology 1999;23(10):1248-55.
1999: Shan Wang-Gohrke; Wolfgang Weikel; Harvey A Risch; Danny Vesprini; JL Abrahamson; C Lerman; A Godwin; Roxana Moslehi; O Olipade; Jean-Sebastien Brunet; Elmar Stickeler; Dirk G Kieback; Rolf Kreienberg; Barbara Weber; Steven A Narod; Ingo B Runnebaum
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.
British journal of cancer 1999;81(1):179-83.
1999: Timothy R Rebbeck; Al Levin; Andrea Eisen; C Snyder; P Watson; Lisa A Cannon-Albright; Claudine Isaacs; Olufunmilayo I Olopade; Judy E Garber; Andrew K Godwin; Mary B Daly; Steven A Narod; Susan L Neuhausen; Henry T Lynch; Barbara L Weber
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Journal of the National Cancer Institute 1999;91(17):1475-9.
1999: Ellen Warner; William D Foulkes; P Goodwin; Wendy S Meschino; John Blondal; C Paterson; Hilmi Ozcelik; P Goss; D Allingham-Hawkins; Nancy Hamel; LS Di Prospero; V Contiga; C Serruya; M Klein; Roxana Moslehi; J Honeyford; Alexander Liede; Gord Glendon; Jean-Sebastien Brunet; Steven A Narod
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
Journal of the National Cancer Institute 1999;91(14):1241-7.
1999: Ronald P Zweemer; Patricia A Shaw; R M Verheijen; A Ryan; Andrew Berchuck; bruce ponder; Harvey A Risch; John R McLaughlin; Steven A Narod; Fred H Menko; Peter Kenemans; Ian J Jacobs
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Journal of clinical pathology 1999;52(5):372-5.
1999: Patricia N Tonin; Anne-Marie Mes-Masson; Steven A Narod; Parviz Ghadirian; Diane Provencher
Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.
Clinical genetics 1999;55(5):318-24.
1999: Timothy R Rebbeck; Philip W Kantoff; K Krithivas; Susan L Neuhausen; M Anne Blackwood; Andrew K Godwin; Mary B Daly; Steven A Narod; Judy E Garber; Henry T Lynch; Barbara L Weber; Myles Brown
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
American journal of human genetics 1999;64(5):1371-7.
1999: A L Millar; T Pal; Lisa Madlensky; C Sherman; Larissa K Temple; A Mitri; H Cheng; Victoria A Marcus; Steven Gallinger; Mark Redston; Bharati Bapat; Steven A Narod
Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
Human molecular genetics 1999;8(5):823-9.
1999: Beth Y Karlan; Rae Lynn Baldwin; E Lopez-Luevanos; Leslie J Raffel; Denise Barbuto; Steven A Narod; Lawrence D Platt
Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
American journal of obstetrics and gynecology 1999;180(4):917-28.
1999: Henry T Lynch; Patrice Watson; Susan Tinley; Carrie Snyder; C Durham; J Lynch; Y Kirnarsky; OM Serova; G Lenoir; Caryn Lerman; Steven A Narod
An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.
Cancer genetics and cytogenetics 1999;109(2):91-8.
1998: T Pal; T Flanders; M Mitchell-Lehman; A MacMillan; Jean-Sebastien Brunet; Steven A Narod; William D Foulkes
Genetic implications of double primary cancers of the colorectum and endometrium.
Journal of medical genetics 1998;35(12):978-84.
1998: Patricia N Tonin; Anne-Marie Mes-Masson; P A Futreal; Kenneth Morgan; M Mahon; William D Foulkes; David E C Cole; Diane Provencher; Parviz Ghadirian; Steven A Narod
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
American journal of human genetics 1998;63(5):1341-51.
1998: Alexander Liede; Kelly A Metcalfe; Kenneth Offit; Karen T Brown; S Miller; Steven A Narod; Roxana Moslehi
A family with three germline mutations in BRCA1 and BRCA2.
Clinical genetics 1998;54(3):215-8.
1998: William D Foulkes; Nora Wong; Jean-Sebastien Brunet; Steven A Narod
BRCA mutations and survival in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3206-8.
1998: Steven A Narod; Harvey A Risch; Roxana Moslehi; A Dørum; Susan L Neuhausen; Håkan Olsson; Diane Provencher; P Radice; G Evans; S Bishop; Jean-Sebastien Brunet; bruce ponder
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
The New England journal of medicine 1998;339(7):424-8.
1998: B Godard; William D Foulkes; Diane Provencher; Jean-Sebastien Brunet; P N Tonin; Anne-Marie Mes-Masson; Steven A Narod; Parviz Ghadirian
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.
American journal of obstetrics and gynecology 1998;179(2):403-10.
1998: Roxana Moslehi; F Solehdin; I Malik; Steven A Narod
Analysis of BRCA1 mutations in a Pakistani family with hereditary breast and ovarian cancer syndrome.
American journal of medical genetics 1998;78(4):386-7.
1998: JL Abrahamson; Roxana Moslehi; Danny Vesprini; Beth Y Karlan; David Fishman; David Smotkin; Yaacov Ben David; H Biran; A Fields; Jean-Sebastien Brunet; Steven A Narod
No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
Cancer research 1998;58(14):2919-22.
1998: M A Musgrave; Kristan J Aronson; Steven A Narod; Wedad M Hanna; Anthony B Miller; David R McCready
Breast cancer and organochlorines: a marker for susceptibility?
Surgical oncology 1998;7(1-2):1-4.
1998: Steven A Narod
Host susceptibility to cancer progression.
American journal of human genetics 1998;63(1):1-5.
1998: Alexander Liede; P Rehal; Danny Vesprini; Elaine Jack; JL Abrahamson; Steven A Narod
A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2.
American journal of human genetics 1998;62(6):1543-4.
1998: Susan L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; Judy E Garber; D Stoppa-Lyonnet; Edith Olah; B Csokay; OM Serova; Fiona Lalloo; A Osorio; Michael Stratton; Kenneth Offit; J Boyd; MA Caligo; R J Scott; A Schofield; E Teugels; M Schwab; Lisa A Cannon-Albright; D Timothy Bishop; Douglas Easton; J Benitez; Mary-Claire King; Bruce A J Ponder; B Weber; Peter Devilee; Ake Borg; Steven A Narod; David E Goldgar
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: Jean-Sebastien Brunet; Parviz Ghadirian; Timothy R Rebbeck; C Lerman; Judy E Garber; P N Tonin; JL Abrahamson; William D Foulkes; Mary Daly; J Wagner-Costalas; A Godwin; Olufunmilayo I Olopade; Roxana Moslehi; Alexander Liede; P A Futreal; B L Weber; G M Lenoir; Henry T Lynch; Steven A Narod
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.
Journal of the National Cancer Institute 1998;90(10):761-6.
1998: William D Foulkes; Nora Wong; F Rozen; Jean-Sebastien Brunet; Steven A Narod
Survival of patients with breast cancer and BRCA1 mutations.
Lancet 1998;351(9112):1359-60.
1998: Caryn Lerman; Chanita Hughes; SJ Lemon; David Main; Carrie Snyder; C Durham; Steven A Narod; Henry T Lynch
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1650-4.
1998: D Ford; Douglas F Easton; Michael Stratton; Steven A Narod; David E Goldgar; Peter Devilee; Tim BISHOP; B Weber; G Lenoir; Jenny Chang-Claude; H Sobol; MD Teare; Jeffery Struewing; Adalgeir Arason; Siegfried Scherneck; Julian Peto; T R Rebbeck; P Tonin; Susan L Neuhausen; Rosa B Barkardottir; Jorunn E Eyfjord; H Lynch; Bruce A J Ponder; Simon A Gayther; M Zelada-Hedman
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
1998: Rosalind A Eeles; Francine Durocher; S Edwards; Dawn M Teare; Michael D Badzioch; Rifat A Hamoudi; S Gill; PJ Biggs; David P Dearnaley; Audrey Ardern-Jones; Anna Dowe; RJ Shearer; D L McLellan; D L McLennan; R L Norman; P Ghadirian; A Aprikian; D Ford; C Amos; Terri King; F Labrie; Jacques Simard; Steven A Narod; Douglas Easton; WD Foulkes
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.
American journal of human genetics 1998;62(3):653-8.
1998: Alexander Liede; P N Tonin; C C Sun; C Serruya; M B Daly; Steven A Narod; William D Foulkes
Is hereditary site-specific ovarian cancer a distinct genetic condition?
American journal of medical genetics 1998;75(1):55-8.
1997: William D Foulkes; Nora Wong; Jean-Sebastien Brunet; Louis R Bégin; J C Zhang; J J Martinez; F Rozen; Patricia N Tonin; Steven A Narod; S E Karp; MN Pollak
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2465-9.
1997: S Sun; Pam Pollock; L Liu; S Karimi; Serge Jothy; B J Milner; A Renwick; Norman Lassam; Nicholas K Hayward; David Hogg; Steven A Narod; William D Foulkes
CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.
International journal of cancer. Journal international du cancer 1997;73(4):531-6.
1997: Graham R Bignell; Federico Canzian; M Shayeghi; M Stark; Yin Yao Shugart; PJ Biggs; J Mangion; Rifat A Hamoudi; Joseph D Rosenblatt; P Buu; S Sun; S S Stoffer; David E Goldgar; Giovanni Romeo; richard Houlston; Steven A Narod; Michael R Stratton; WD Foulkes
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
American journal of human genetics 1997;61(5):1123-30.
1997: Harriet Druker; Lidia Kasprzak; L R Bégin; Serge Jothy; Steven A Narod; William D Foulkes
Family with Graves disease, multinodular goiter, nonmedullary thyroid carcinoma, and alveolar rhabdomyosarcoma.
American journal of medical genetics 1997;72(1):30-3.
1997: J N Marcus; Patrice Watson; D L Page; Steven A Narod; P Tonin; Gilbert M Lenoir; OM Serova; Henry T Lynch
BRCA2 hereditary breast cancer pathophenotype.
Breast cancer research and treatment 1997;44(3):275-7.
1997: Nazneen Rahman; Laura Arbour; P Tonin; Sylvain Baruchel; Kathy Pritchard-Jones; Steven A Narod; Michael R Stratton
The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Oncogene 1997;14(25):3099-102.
1997: Henry T Lynch; SJ Lemon; C Durham; Susan Tinley; C Connolly; Jane F Lynch; J Surdam; E Orinion; S Slominski-Caster; Patrice Watson; Caryn Lerman; P Tonin; G Lenoir; OM Serova; Steven A Narod
A descriptive study of BRCA1 testing and reactions to disclosure of test results.
Cancer 1997;79(11):2219-28.
1997: H Ozçelik; Beverly Schmocker; Nando Di Nicola; X H Shi; B Langer; M Moore; B R Taylor; Steven A Narod; G Darlington; Irene L Andrulis; Steven Gallinger; Mark Redston
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.
Nature genetics 1997;16(1):17-8.
1997: Jean-Sebastien Brunet; Steven A Narod; Patricia N Tonin; William D Foulkes
BRCA1 mutations and survival in women with ovarian cancer.
The New England journal of medicine 1997;336(17):1256; author reply 1256-7.
1997: OM Serova; Sylvie Mazoyer; Nadine Puget; V Dubois; P Tonin; Yin Yao Shugart; David E Goldgar; Steven A Narod; Henry T Lynch; Gilbert M Lenoir
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
American journal of human genetics 1997;60(3):486-95.
1997: Steven A Narod; Mike M Hawkins; C M Robertson; C A Stiller
Congenital anomalies and childhood cancer in Great Britain.
American journal of human genetics 1997;60(3):474-85.
1996: Corey Cutler; William D Foulkes; Jean-Sebastien Brunet; T Y Flanders; H Shibata; Steven A Narod
Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first-degree relatives: a case-control study.
Melanoma research 1996;6(6):435-40.
1996: Francine Durocher; Patricia N Tonin; D Shattuck-Eidens; M Skolnick; Steven A Narod; Jacques Simard
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.
Journal of medical genetics 1996;33(10):814-9.
1996: William D Foulkes; Jean-Sebastien Brunet; W Sieh; Martin J Black; George Shenouda; Steven A Narod
Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.
BMJ (Clinical research ed.) 1996;313(7059):716-21.
1996: Bharati Bapat; L Xia; Lisa Madlensky; A Mitri; Patricia N Tonin; Steven A Narod; Steven Gallinger
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.
American journal of human genetics 1996;59(3):736-9.
1996: William D Foulkes; N Bolduc; D Lambert; O Ginsburg; L Olien; D W Yandell; Patricia N Tonin; Steven A Narod
Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.
Journal of medical genetics 1996;33(7):534-9.
1996: Caryn Lerman; Steven A Narod; Kevin Schulman; Chanita Hughes; A Gomez-Caminero; G Bonney; Karen Gold; Bruce J Trock; David Main; J Lynch; C Fulmore; Carrie Snyder; SJ Lemon; T Conway; Patricia N Tonin; G Lenoir; Henry T Lynch
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
JAMA : the journal of the American Medical Association 1996;275(24):1885-92.
1996: CM Phelan; Catharina Larsson; S Baird; P Andrew Futreal; M H Ruttledge; K Morgan; Patricia N Tonin; H Hung; R G Korneluk; M N Pollak; Steven A Narod
The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.
Genomics 1996;34(1):63-8.
1996: CM Phelan; Johnathan M Lancaster; Patricia N Tonin; Curtis Gumbs; C Cochran; R Carter; Parviz Ghadirian; C Perret; Roxana Moslehi; F Dion; M C Faucher; K Dole; S Karimi; William D Foulkes; H Lounis; Ellen Warner; P Goss; D Anderson; Catharina Larsson; Steven A Narod; P Andrew Futreal
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Nature genetics 1996;13(1):120-2.
1996: CM Phelan; Timothy R Rebbeck; Barbara L Weber; Peter Devilee; M H Ruttledge; H T Lynch; Gilbert M Lenoir; Michael R Stratton; D F Easton; Bruce A J Ponder; Lisa A Cannon-Albright; Catharina Larsson; D E Goldgar; Steven A Narod
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Nature genetics 1996;12(3):309-11.
1996: J N Marcus; Patrice Watson; D L Page; Steven A Narod; Gilbert M Lenoir; Patricia N Tonin; L Linder-Stephenson; G Salerno; T A Conway; Henry T Lynch
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
Cancer 1996;77(4):697-709.
1996: Susan L Neuhausen; Sylvie Mazoyer; L Friedman; Michael Stratton; Kenneth Offit; A Caligo; Gail Tomlinson; Lisa A Cannon-Albright; D Timothy Bishop; D Kelsell; E Solomon; B Weber; Fergus J. Couch; Jeffery Struewing; Patricia N Tonin; Francine Durocher; Steven A Narod; Mark H Skolnick; G Lenoir; OM Serova; Bruce A J Ponder; D Stoppa-Lyonnet; Douglas Easton; Mary-Claire King; David E Goldgar
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
1996: William D Foulkes; Steven A Narod
Screening for cancer in high-risk families.
Cancer treatment and research 1996;86():165-82.
1996: OM Serova; Marco Montagna; D Torchard; Steven A Narod; Patricia N Tonin; Bakary S Sylla; Henry T Lynch; Jean Feunteun; Gilbert M Lenoir
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
American journal of human genetics 1996;58(1):42-51.
1995: Steven A Narod; D Goldgar; Lisa A Cannon-Albright; Barbara Weber; Roxana Moslehi; E Ives; G Lenoir; Henry T Lynch
Risk modifiers in carriers of BRCA1 mutations.
International journal of cancer. Journal international du cancer 1995;64(6):394-8.
1995: William D Foulkes; Jean-Sebastien Brunet; Luiz Paulo Kowalski; Steven A Narod; Eduardo L Franco
Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study.
International journal of cancer. Journal international du cancer 1995;63(6):769-73.
1995: Patricia N Tonin; Parviz Ghadirian; CM Phelan; Gilbert M Lenoir; Henry T Lynch; F Letendre; D Belanger; M Monté; Steven A Narod
A large multisite cancer family is linked to BRCA2.
Journal of medical genetics 1995;32(12):982-4.
1995: Steven A Narod; D Ford; Peter Devilee; Rosa B Barkardottir; J Eyfjord; G Lenoir; OM Serova; Douglas Easton; David E Goldgar
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;57(4):957-8.
1995: Johanna M Rommens; Francine Durocher; J McArthur; Patricia N Tonin; J F LeBlanc; T Allen; C Samson; L Ferri; Steven A Narod; Kenneth Morgan
Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21.
Genomics 1995;28(3):530-42.
1995: William D Foulkes; Gord Glendon; Steven A Narod
Family history and risk of ovarian cancer.
JAMA : the journal of the American Medical Association 1995;274(5):383.
1995: Patricia N Tonin; OM Serova; G Lenoir; H Lynch; Francine Durocher; Jacques Simard; Kenneth Morgan; Steven A Narod
BRCA1 mutations in Ashkenazi Jewish women.
American journal of human genetics 1995;57(1):189.
1995: Steven A Narod; O Ginsburg; Serge Jothy
Family history and colorectal cancer.
The New England journal of medicine 1995;332(23):1578; author reply 1579.
1995: D Shattuck-Eidens; M McClure; Jacques Simard; Fernand Labrie; Steven A Narod; Fergus J. Couch; K Hoskins; B Weber; L Castilla; M Erdos
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.
JAMA : the journal of the American Medical Association 1995;273(7):535-41.
1995: Steven A Narod; D Ford; Peter Devilee; Rosa B Barkardottir; Henry T Lynch; S A Smith; B A Ponder; B L Weber; Judy E Garber; J M Birch
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;56(1):254-64.
1994: J Wagner; C Portwine; K Rabin; Jean-Marie Leclerc; Steven A Narod; D Malkin
High frequency of germline p53 mutations in childhood adrenocortical cancer.
Journal of the National Cancer Institute 1994;86(22):1707-10.
1994: Steven A Narod; Lisa Madlensky; L Bradley; D Cole; Patricia N Tonin; B Rosen; H A Risch
Hereditary and familial ovarian cancer in southern Ontario.
Cancer 1994;74(8):2341-6.
1994: Patricia N Tonin; OM Serova; Jacques Simard; G Lenoir; Jean Feunteun; Kenneth Morgan; H Lynch; Steven A Narod
The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.
Human molecular genetics 1994;3(9):1679-82.
1994: L Arbour; Steven A Narod; Gord Glendon; M Pollak; R Seymour; L Miner; P Leung
In-vitro fertilisation and family history of breast cancer.
Lancet 1994;344(8922):610-1.
1994: Steven A Narod
Genetics of breast and ovarian cancer.
British medical bulletin 1994;50(3):656-76.
1994: R C Green; Steven A Narod; J Morasse; TL Young; J Cox; G W Fitzgerald; Patricia N Tonin; O Ginsburg; S Miller; Serge Jothy
Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.
American journal of human genetics 1994;54(6):1067-77.
1994: Steven A Narod; Patricia N Tonin; H Lynch; Patrice Watson; Jean Feunteun; G Lenoir
Histology of BRCA1-associated ovarian tumours.
Lancet 1994;343(8891):236.
1994: Henry T Lynch; J Lynch; T Conway; Patrice Watson; Jean Feunteun; G Lenoir; Steven A Narod; Robert J Fitzgibbons
Hereditary breast cancer and family cancer syndromes.
World journal of surgery 1994;18(1):21-31.
1994: D Torchard; C Blanchet-Bardon; OM Serova; L Langbein; Steven A Narod; Nicolas Janin; AF Goguel; Alain BERNHEIM; W W Franke; Gilbert M Lenoir
Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer.
Nature genetics 1994;6(1):106-10.
1993: P Lalle; D Stoppa-Lyonnet; Sylvie Mazoyer; Pascale G Rio; C Girodet; Agnès Hardouin; Steven A Narod; H Sobol; Yves-Jean Bignon
[Hereditary predisposition for cancer of the breast and the ovary].
Bulletin du cancer 1993;80(10):857-65.
1993: Henry T Lynch; Patrice Watson; T A Conway; Jane F Lynch; S M Slominski-Caster; Steven A Narod; Jean Feunteun; G Lenoir
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Archives of internal medicine 1993;153(17):1979-87.
1993: M H Ruttledge; Steven A Narod; Jan P Dumanski; Dilys M Parry; R Eldridge; W Wertelecki; J Parboosingh; M C Faucher; Gilbert M Lenoir; V Peter Collins
Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.
Neurology 1993;43(9):1753-60.
1993: P Lalle; Yves-Jean Bignon; D Stoppa-Lyonnet; Steven A Narod; Sylvie Mazoyer; Pascale G Rio; F Courjal; P Bartholin; H Sobol
Screening of inherited breast cancer with DNA markers.
Lancet 1993;341(8857):1422.
1993: Steven A Narod; H Lynch; T Conway; Patrice Watson; Jean Feunteun; G Lenoir
Increasing incidence of breast cancer in family with BRCA1 mutation.
Lancet 1993;341(8852):1101-2.
1993: Sylvie Mazoyer; P Lalle; Steven A Narod; Yves-Jean Bignon; F Courjal; B Jamot; B Dutrillaux; D Stoppa-Lyonnett; H Sobol
Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.
American journal of human genetics 1993;52(4):754-60.
1993: H Sobol; Sylvie Mazoyer; S A Smith; D Lyonnet; Yves-Jean Bignon; Steven A Narod; A Ardoin; P Biron; J Y Bobin; A Bremond
Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
Bulletin du cancer 1993;80(2):121-34.
1992: Steven A Narod; Dilys M Parry; J Parboosingh; Gilbert M Lenoir; M Ruttledge; G Fischer; R Eldridge; R L Martuza; M Frontali; Jonathan L Haines
Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
American journal of human genetics 1992;51(3):486-96.
1992: Steven A Narod; M F Lavoué; Kenneth Morgan; C Calmettes; H Sobol; Paul J Goodfellow; Gilbert M Lenoir
Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.
American journal of human genetics 1992;51(3):469-77.
1992: H Sobol; Sylvie Mazoyer; Steven A Narod; S A Smith; D M Black; P Kerbrat; B Jamot; E Solomon; B A Ponder; D Guerin
Genetic heterogeneity of early-onset familial breast cancer.
Human genetics 1992;89(4):381-3.
1992: E M Lamothe; Steven A Narod; S Miller; Paul J Goodfellow; David E C Cole; D Gilchrist; Zdenka Pausova; David Goltzman; Geoffrey N Hendy
Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
Henry Ford Hospital medical journal 1992;40(3-4):224-6.
1991: Steven A Narod; Jean Feunteun; Henry T Lynch; P Watson; T Conway; J Lynch; Gilbert M Lenoir
Familial breast-ovarian cancer locus on chromosome 17q12-q23.
Lancet 1991;338(8759):82-3.
1991: Steven A Narod; S De Sanjosé; Cesar Victora
Coffee during pregnancy: a reproductive hazard?
American journal of obstetrics and gynecology 1991;164(4):1109-14.
1991: Steven A Narod; H Sobol; I Schuffenecker; M F Lavoué; Gilbert M Lenoir
The gene for MEN 2A is tightly linked to the centromere of chromosome 10.
Human genetics 1991;86(5):529-30.
1991: M Maillet-Vioud; Steven A Narod; D Assouline; H Sobol; G Fischer; J M Robert; Gilbert M Lenoir
[Genetics of neurofibromatosis: recent progress and prospects].
Revue neurologique 1991;147(10):644-52.
1991: Steven A Narod
Power of the admixture test to detect genetic heterogeneity.
Genetic epidemiology 1991;8(4):209-16.
1991: I Schuffenecker; Steven A Narod; R A Ezekowitz; H Sobol; Jean Feunteun; Gilbert M Lenoir
The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2.
Cytogenetics and cell genetics 1991;56(2):99-102.
1990: Gilbert M Lenoir; Steven A Narod; B A Ponder
Workshop on linkage studies of hereditary breast cancer.
Cancer research 1990;50(14):4448-9.
1990: D Assouline; H Sobol; M Maillet-Vioud; I Schuffenecker; Steven A Narod; Gilbert M Lenoir
[Heredity and medullary cancer of the thyroid].
La Revue du praticien 1990;40(16):1487-9.
1990: Steven A Narod; C Amos
Estimating the power of linkage analysis in hereditary breast cancer.
American journal of human genetics 1990;46(2):266-72.
1990: Steven A Narod
Radiation, genetics and childhood leukaemia.
European journal of cancer (Oxford, England : 1990) 1990;26(6):661-4.
1989: Steven A Narod; H Sobol; Y Nakamura; C Calmettes; Jean-Louis Baulieu; Jean-Claude Bigorgne; G Chabrier; J Couette; J L de Gennes; J Duprey
Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.
Human genetics 1989;83(4):353-8.
1989: H Sobol; Steven A Narod; Y Nakamura; A Boneu; C Calmettes; D Chadenas; G Charpentier; J F Chatal; N Delepine; M J Delisle
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.
The New England journal of medicine 1989;321(15):996-1001.
1989: Steven A Narod; Ian D Dubé
Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia.
Cancer genetics and cytogenetics 1989;38(2):261-9.
1989: H Sobol; Steven A Narod; I Schuffenecker; C Amos; R A Ezekowitz; Gilbert M Lenoir
Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Henry Ford Hospital medical journal 1989;37(3-4):109-11.
1989: Steven A Narod; H Sobol; I Schuffenecker; R A Ezekowitz; Gilbert M Lenoir
Early detection of hereditary medullary thyroid cancer with polymorphic DNA probes. Groupe d'Etude des Tumeurs a Calcitonine.
Henry Ford Hospital medical journal 1989;37(3-4):106-8.
1989: H Sobol; Steven A Narod; D Assouline; Gilbert M Lenoir
Genetic screening of endocrine tumour syndromes with DNA probes: the example of medullary thyroid carcinoma.
Hormone research 1989;32(1-3):34-40.
1988: Steven A Narod; J Siegel-Bartelt; H J Hoffman
Cerebellar infarction in a patient with Waardenburg syndrome.
American journal of medical genetics 1988;31(4):903-7.